Healthcare Realty Trust (HR) 10-Q 9 Nov 22 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2022	Nov. 04, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-35568
Entity Registrant Name	HEALTHCARE REALTY TRUST INCORPORATED
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	20-4738467
Entity Address, Address Line One	3310 West End Avenue
Entity Address, Address Line Two	Suite 700
Entity Address, City or Town	Nashville
Entity Address, State or Province	TN
Entity Address, Postal Zip Code	37203
City Area Code	615
Local Phone Number	269-8175
Title of 12(b) Security	Class A Common Stock, $0.01 par value per share
Trading Symbol	HR
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		380,572,290
Entity Central Index Key	0001360604
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Real estate properties
Land	$ 1,449,550	$ 387,918
Buildings and improvements	11,439,797	4,337,641
Lease intangibles	968,914	120,478
Personal property	11,680	11,761
Investment in financing receivable, net	118,919	186,745
Financing lease right-of-use assets	79,950	31,576
Construction in progress	43,148	3,974
Land held for development	73,321	24,849
Total real estate properties	14,185,279	5,104,942
Less accumulated depreciation and amortization	(1,468,736)	(1,338,743)
Total real estate properties, net	12,716,543	3,766,199
Cash and cash equivalents	57,583	13,175
Assets held for sale, net	185,074	57
Operating lease right-of-use assets	321,365	128,386
Investments in unconsolidated joint ventures	327,752	161,942
Goodwill	148,891	3,487
Other assets, net	438,235	185,673
Total assets	14,195,443	4,258,919
Liabilities
Notes and bonds payable	5,570,139	1,801,325
Accounts payable and accrued liabilities	231,018	86,108
Liabilities of assets held for sale	10,644	294
Operating lease liabilities	268,840	96,138
Financing lease liabilities	72,378	22,551
Other liabilities	203,398	67,387
Total liabilities	6,356,417	2,073,803
Commitments and contingencies
Stockholders' equity
Preferred stock, $.01 par value per share; 200,000 shares authorized; none issued and outstanding	0	0
Class A Common stock, $.01 par value per share; 1,000,000 shares authorized; 380,572 and 150,457 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively	3,806	1,505
Additional paid-in capital	9,586,556	3,972,917
Accumulated other comprehensive income (loss)	5,524	(9,981)
Cumulative net income attributable to common stockholders	1,342,819	1,266,158
Cumulative dividends	(3,211,492)	(3,045,483)
Total stockholders' equity	7,727,213	2,185,116
Non-controlling interest	111,813	0
Total equity	7,839,026	2,185,116
Total liabilities and equity	$ 14,195,443	$ 4,258,919

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Preferred stock, par value (dollars per share)	$ 0.01	$ 0.01
Preferred stock, authorized (shares)	200,000,000	200,000,000
Preferred stock, issued (shares)	0	0
Preferred stock, outstanding (shares)	0	0
Common stock, par value (dollars per share)	$ 0.01	$ 0.01
Common stock, authorized (shares)	1,000,000,000	1,000,000,000
Common stock, issued (shares)	380,572,000	150,457,000
Common stock, outstanding (shares)	380,572,000	150,457,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues
Rental income	$ 298,931	$ 131,746	$ 578,052	$ 388,620
Interest income	3,366	1,917	7,253	2,426
Other operating	4,057	2,969	9,270	7,347
Revenues	306,354	136,632	594,575	398,393
Expenses
Property operating	112,473	55,518	226,947	159,241
General and administrative	16,741	8,207	38,317	25,251
Acquisition and pursuit costs	482	974	3,137	2,388
Merger-related costs	79,402	0	92,603	0
Depreciation and amortization	158,117	50,999	267,889	150,904
Expenses	367,215	115,698	628,893	337,784
Other income (expense)
Gain on sales of real estate properties	143,908	1,186	197,188	41,046
Interest expense	(53,044)	(13,334)	(82,248)	(39,857)
Loss on extinguishment of debt	(1,091)	0	(2,520)	0
Impairment of real estate properties	0	(10,669)	25	(16,581)
Equity loss from unconsolidated joint ventures	(124)	(183)	(776)	(404)
Interest and other (expense) income, net	(172)	0	(378)	239
Total other income (expense)	89,477	(23,000)	111,291	(15,557)
Net income (loss)	28,616	(2,066)	76,973	45,052
Net income attributable to non-controlling interests	(312)	0	(312)	0
Net income (loss) attributable to common stockholders	$ 28,304	$ (2,066)	$ 76,661	$ 45,052
Basic earnings per common share (in dollars per share)	$ 0.08	$ (0.02)	$ 0.36	$ 0.31
Diluted earnings per common share (in dollars per share)	$ 0.08	$ (0.02)	$ 0.35	$ 0.31
Weighted average common shares outstanding - basic	328,805,255	143,817,619	209,806,810	141,521,193
Weighted average common shares outstanding - diluted	332,031,384	143,817,619	210,943,990	141,613,429
Revenue, Product and Service [Extensible List]	Service [Member]	Service [Member]

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net income (loss)	$ 28,304	$ (2,066)	$ 76,661	$ 45,052
Interest rate swaps
Reclassification adjustments for losses included in net income (interest expense)	763	1,131	2,672	3,340
Gains arising during the period on interest rate swaps	6,083	36	12,905	2,079
Other comprehensive income	6,846	1,167	15,577	5,419
Comprehensive income (loss)	35,462	(899)	92,550	50,471
Less: comprehensive income attributable to non-controlling interests	(384)	0	(384)	0
Comprehensive income (loss) attributable to common stockholders	35,078	(899)	92,166	50,471
Net income, including portion attributable to noncontrolling interest	28,616	(2,066)	76,973	45,052
Interest Rate Swaps
Interest rate swaps
Gains arising during the period on interest rate swaps	$ 6,083	$ 36	$ 12,905	$ 2,079

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Equity - USD ($) $ in Thousands	Total	Total Stockholders’ Equity	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Cumulative Net Income	Cumulative Dividends	Non-controlling Interests
Beginning balance at Dec. 31, 2020	$ 1,948,376		$ 1,395	$ 3,635,341	$ (17,832)	$ 1,199,499	$ (2,870,027)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs	240,738		78	240,660
Common stock redemptions	(1,610)			(1,610)
Share-based compensation	8,183		2	8,181
Net income (loss)	45,052					45,052
Net income attributable to non-controlling interests	0
Net income, including portion attributable to noncontrolling interest	45,052
Reclassification adjustments for losses included in net income (interest expense)	3,340				3,340
Gains (Losses) arising during the period on interest rate swaps	2,079				2,079
Dividends to common stockholders (in usd per share)	(130,825)						(130,825)
Ending balance at Sep. 30, 2021	2,115,333	$ 2,115,333	1,475	3,882,572	(12,413)	1,244,551	(3,000,852)	0
Beginning balance at Jun. 30, 2021	2,096,254	2,096,254	1,455	3,818,592	(13,580)	1,246,617	(2,956,830)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs	61,462	61,462	20	61,442
Common stock redemptions	0	0		0
Share-based compensation	2,538	2,538		2,538
Net income (loss)	(2,066)	(2,066)				(2,066)
Net income attributable to non-controlling interests	0
Net income, including portion attributable to noncontrolling interest	(2,066)
Reclassification adjustments for losses included in net income (interest expense)	1,131	1,131			1,131
Gains (Losses) arising during the period on interest rate swaps	36	36			36
Dividends to common stockholders (in usd per share)	(44,022)	(44,022)					(44,022)
Ending balance at Sep. 30, 2021	2,115,333	2,115,333	1,475	3,882,572	(12,413)	1,244,551	(3,000,852)	0
Beginning balance at Dec. 31, 2021	2,185,116	2,185,116	1,505	3,972,917	(9,981)	1,266,158	(3,045,483)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs	22,855	22,855	8	22,847
Merger consideration transferred	5,687,165	5,576,463	2,289	5,574,174
Merger consideration transferred, non controlling cost,								110,702
Non-controlling interests acquired	1,266							1,266
Common stock redemptions	(248)	(248)		(248)
Share-based compensation	16,772	16,772	4	16,768
Redemption of non-controlling interest	1	98		98				(97)
Net income (loss)	76,661	76,661				76,661
Net income attributable to non-controlling interests	312							312
Net income, including portion attributable to noncontrolling interest	76,973
Reclassification adjustments for losses included in net income (interest expense)	2,672	2,664			2,664			8
Gains (Losses) arising during the period on interest rate swaps	12,905	12,841			12,841			64
Dividends to common stockholders (in usd per share)	(166,451)	(166,009)					(166,009)	(442)
Ending balance at Sep. 30, 2022	7,839,026	7,727,213	3,806	9,586,556	5,524	1,342,819	(3,211,492)	111,813
Beginning balance at Jun. 30, 2022	2,177,866	2,177,866	1,516	4,002,525	(1,250)	1,314,515	(3,139,440)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs	84	84	0	84
Merger consideration transferred	5,687,165	5,576,463	2,289	5,574,174
Merger consideration transferred, non controlling cost,								110,702
Non-controlling interests acquired	1,266							1,266
Common stock redemptions	(41)	(41)		(41)
Share-based compensation	9,717	9,717	1	9,716
Redemption of non-controlling interest	1	98		98				(97)
Net income (loss)	28,304	28,304				28,304
Net income attributable to non-controlling interests	312							312
Net income, including portion attributable to noncontrolling interest	28,616
Reclassification adjustments for losses included in net income (interest expense)	763	755			755			8
Gains (Losses) arising during the period on interest rate swaps	6,083	6,019			6,019			64
Dividends to common stockholders (in usd per share)	(72,494)	(72,052)					(72,052)	(442)
Ending balance at Sep. 30, 2022	$ 7,839,026	$ 7,727,213	$ 3,806	$ 9,586,556	$ 5,524	$ 1,342,819	$ (3,211,492)	$ 111,813

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Equity (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Stockholders' Equity [Abstract]
Dividend per share to common Stockholders (in dollars per share)	$ 0.31	$ 0.3025	$ 0.93	$ 0.9075

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
OPERATING ACTIVITIES
Net income	$ 76,973	$ 45,052
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	267,889	150,904
Other amortization	11,875	2,721
Share-based compensation	16,772	8,183
Amortization of straight-line rent receivable (lessor)	(12,267)	(4,574)
Amortization of straight-line rent on operating leases (lessee)	2,016	1,115
Gain on sales of real estate properties	(197,188)	(41,046)
Loss on extinguishment of debt	2,520	0
Impairment of real estate properties	(25)	16,581
Equity loss from unconsolidated joint ventures	776	404
Distributions from unconsolidated joint ventures	893	0
Non-cash interest from financing and notes receivable	(1,901)	(196)
Changes in operating assets and liabilities:
Other assets, including right-of-use-assets	(19,230)	(9,947)
Accounts payable and accrued liabilities	35,769	215
Other liabilities	(58,213)	843
Net cash provided by operating activities	126,659	170,255
INVESTING ACTIVITIES
Acquisitions of real estate	(376,924)	(250,766)
Development of real estate	(17,572)	(2,020)
Additional long-lived assets	(97,797)	(69,647)
Funding of mortgages and notes receivable	(3,441)	0
Investments in unconsolidated joint ventures	(99,586)	(49,612)
Investment in financing receivable	167
Investment in financing receivable		(104,654)
Proceeds from sales of real estate properties and additional long-lived assets	870,806	112,029
Proceeds from notes receivable repayments	500	0
Cash assumed in Merger, including restricted cash for special dividend payment	1,149,681	0
Net cash provided by (used in) investing activities	1,425,834	(364,670)
FINANCING ACTIVITIES
Net (repayments)/borrowings on unsecured credit facility	(154,400)	90,500
Borrowings on term loans	666,500	0
Repayment on term loan	(718,500)	0
Repayments of notes and bonds payable	(18,880)	(2,914)
Redemption of notes and bonds payable	(2,184)	0
Dividends paid	(165,735)	(130,825)
Special dividend paid in relation to the Merger	(1,123,648)	0
Net proceeds from issuance of common stock	22,851	240,779
Common stock redemptions	(894)	(2,014)
Distributions to non-controlling interest holders	(442)	0
Debt issuance and assumption costs	(12,753)	(252)
Payments made on finance leases	0	(162)
Net cash (used in) provided by financing activities	(1,508,085)	195,112
Increase in cash and cash equivalents	44,408	697
Cash and cash equivalents at beginning of period	13,175	15,303
Cash and cash equivalents at end of period	57,583	16,000
Supplemental Cash Flow Information
Interest paid	83,382	40,653
Invoices accrued for construction, tenant improvements and other capitalized costs	52,840	11,663
Capitalized interest	$ 848	$ 187

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Business Overview Healthcare Realty Trust Incorporated is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of September 30, 2022, the Company had gross investments of approximately $14.2 billion in 695 real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development and corporate property. The Company's 695 real estate properties are located in 35 states and total approximately 40.7 million square feet. The Company provided leasing and property management services to approximately 38.9 million square feet nationwide. As of September 30, 2022, the Company had a weighted average ownership interest of approximately 49% in 33 real estate properties held in joint ventures. See Note 3 below for more details regarding the Company's unconsolidated joint ventures. Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the Company's Condensed Consolidated Financial Statements, are outside the scope of our independent registered public accounting firm’s review. Basis of Presentation For purposes of this Quarterly Report on Form 10-Q, references to the “Company” are to Legacy HR for periods prior to the closing of the Merger and thereafter to Legacy HR and Legacy HTA after giving effect to the Merger. The Merger is described in more detail in Note 2 to these Condensed Consolidated Financial Statements. The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. However, except as disclosed herein and specific disclosures incorporated as a result of the Merger, management believes there has been no material change in the information disclosed in the Notes to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2021. All material intercompany transactions and balances have been eliminated in consolidation. This interim financial information should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. In addition, the interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2022 for many reasons including, but not limited to, the Merger (as discussed in more detail in Note 2 below), acquisitions, dispositions, capital financing transactions, changes in interest rates and the effects of other trends, risks and uncertainties. Principles of Consolidation The Company’s Condensed Consolidated Financial Statements include, as of September 30, 2022, the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. The interests not owned by the Company are presented as non-controlling interests on the accompanying Condensed Consolidated Balance Sheets and Statements of Operations, Condensed Consolidated Statements of Comprehensive Income, and Condensed Consolidated Statements of Equity. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (“VIEs”). Accounting Standards Codification 810 broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity’s economic performance or (ii) the equity investment at risk is insufficient to finance that entity’s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact the entity’s economic performance; and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE’s primary beneficiary. The Company may change its original assessment of a VIE upon subsequent events such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity’s equity investments at risk and the disposition of all or a portion of an interest held by the primary beneficiary. The Company performs this analysis on an ongoing basis. As of September 30, 2022, the Company identified three entities that qualified as VIE's because the limited partners in these partnerships, although entitled to vote on certain matters, do not possess kick-out rights or substantive participating rights. Two of the entities are consolidated and one is unconsolidated. Holders of operating partnership units (“OP Units”) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Condensed Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of September 30, 2022, there were approximately 4.0 million, or 1.1%, of OP Units issued and outstanding held by non-controlling interest holders. Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates the interests in the OP. However, because the Company holds what is deemed to be significantly all of the OP, it qualifies for the exemption from providing certain disclosure requirements associated with investments in VIEs. For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. As of September 30, 2022, the Company's unconsolidated joint venture arrangements were accounted for using the equity method of accounting as the Company exercised significant influence over but did not control these entities. See Note 3 below for more details regarding the Company's unconsolidated joint ventures. Use of Estimates in the Condensed Consolidated Financial Statements Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates. Reclassifications Certain reclassifications have been made on the Company's prior year Condensed Consolidated Balance Sheet to conform to current year presentation. Previously, the Company's Lease intangibles were included in Building, improvements and lease intangibles and Goodwill was included with Other assets, net. These amounts are now classified as separate line items on the Company's Condensed Consolidated Balance Sheets. Investments in Leases - Financing Receivables, Net In accordance with Accounting Standards Codification ("ASC") 842, for transactions in which the Company enters into a contract to acquire an asset and leases it back to the seller (i.e., a sale leaseback transaction), control of the asset is not considered to have transferred when the seller-lessee has a purchase option. As a result, the Company does not recognize the underlying real estate asset but instead recognizes a financial asset in accordance with ASC 310 “Receivables”. During the first quarter of 2022, the Company reclassified the two medical office buildings in Nashville, Tennessee that were acquired in separate sale-leaseback transactions in the fourth quarter of 2021. The leases with the sellers commenced in the first quarter, which resulted in the allocation of the financing receivable totaling $73.9 million to land and building and improvements. Real Estate Notes Receivable Real estate notes receivable consists of mezzanine and other real estate loans, which are generally collateralized by a pledge of the borrower’s ownership interest in the respective real estate owner, a mortgage or deed of trust, and/or corporate guarantees. Real estate notes receivable are intended to be held-to-maturity and are recorded at amortized cost, net of unamortized loan origination costs and fees and allowance for credit losses. As of September 30, 2022, real estate notes receivable, net totaled $79.0 million. Interest Income Income from Lease Financing Receivables For the three and nine months ended September 30, 2022, the Company recognized the related income from two financing receivables totaling $2.0 million and $5.9 million, respectively, based on an imputed interest rate over the terms of the applicable lease. As a result, the interest recognized from the financing receivable will not equal the cash payments from the lease agreement. Acquisition costs incurred in connection with entering into the financing receivable are treated as loan origination fees. These costs are classified with the financing receivable and are included in the balance of the net investment. Amortization of these amounts will be recognized as a reduction to Income from financing receivable, net over the life of the lease. Income from Real Estate Notes Receivable During the three and nine months ended September 30, 2022, the Company recognized interest income of $1.3 million related to real estate notes receivable. Unpaid interest is capitalized, with principal and any unpaid interest due on the maturity date. Revenue from Contracts with Customers (Topic 606) The Company recognizes certain revenue under the core principle of Topic 606. This topic requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of Topic 606. To achieve the core principle, the Company applies the five step model specified in the guidance. Revenue that is accounted for under Topic 606 is segregated on the Company’s Condensed Consolidated Statements of Income in the Other operating line item. This line item includes parking income, management fee income and other miscellaneous income. Below is a detail of the amounts by category: THREE MONTHS ENDED NINE MONTHS ENDED in thousands 2022 2021 2022 2021 Type of Revenue Parking income $ 2,428 $ 2,187 $ 6,100 $ 5,725 Management fee income 1 1,426 723 2,864 1,381 Miscellaneous 203 59 306 241 $ 4,057 $ 2,969 $ 9,270 $ 7,347 1 Includes the recovery of certain expenses under the financing receivable as outlined in the management agreement. The Company’s major types of revenue that are accounted for under Topic 606 that are listed above are all accounted for as the performance obligation is satisfied. The performance obligations that are identified for each of these items are satisfied over time, and the Company recognizes revenue monthly based on this principle. New Accounting Pronouncements Accounting Standards Update No. 2020-04 On March 12, 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-04, Reference Rate Reform (Topic 848)

Merger with HTA

Merger with HTA	9 Months Ended
	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Merger with HTA	Merger with HTA On July 20, 2022 (the “Closing Date”), pursuant to the Agreement and Plan of Merger dated as of February 28, 2022 (the “Merger Agreement”), by and among Healthcare Realty Trust Incorporated, a Maryland corporation (now known as HRTI, LLC, a Maryland limited liability company) (“Legacy HR”), Healthcare Trust of America, Inc., a Maryland corporation (now known as Healthcare Realty Trust Incorporated) (“Legacy HTA”), Healthcare Trust of America Holdings, LP, a Delaware limited partnership (now known as Healthcare Realty Holdings, L.P.) (the “OP”), and HR Acquisition 2, LLC, a Maryland limited liability company (“Merger Sub”), Merger Sub merged with and into Legacy HR, with Legacy HR continuing as the surviving entity and a wholly-owned subsidiary of Legacy HTA (the “Merger”). On the Closing Date, each outstanding share of Legacy HR common stock, $0.01 par value per share (the “Legacy HR Common Stock”), was cancelled and converted into the right to receive one share of Legacy HTA class A common stock at a fixed ratio of 1.00 to 1.00. Per the terms of the Merger Agreement, Legacy HTA declared a special dividend of $4.82 (the “Special Dividend”) for each outstanding share of Legacy HTA class A common stock, $0.01 par value per share ( the “Legacy HTA Common Stock”), and the OP declared a corresponding distribution to the holders of its partnership units, payable to Legacy HTA stockholders and OP unitholders of record on July 19, 2022. Immediately following the Merger, Legacy HR converted to a Maryland limited liability company and changed its name to HRTI, LLC and Legacy HTA changed its name to “Healthcare Realty Trust Incorporated”. In addition, the equity interests of Legacy HR were contributed by Legacy HTA by means of a contribution and assignment agreement to the OP such that Legacy HR became a wholly-owned subsidiary of the OP. As a result, Legacy HR became a part of an umbrella partnership REIT (“UPREIT”) structure, which is intended to align the corporate structure of the combined company after giving effect to the Merger and UPREIT reorganization (the “Combined Company”). The combined company operates under the name “Healthcare Realty Trust Incorporated” and its shares of class A common stock, $0.01 par value per share, trade on the New York Stock Exchange (the “NYSE”) under the ticker symbol “HR”. The primary reason for the Merger was to expand the Company’s size, scale, diversification, liquidity and access to capital, in order to further enhance its competitive advantages and accelerate its investment activities. For accounting purposes, the Merger was treated as a “reverse acquisition” in which Legacy HTA was considered the legal acquirer and Legacy HR was considered the accounting acquirer based on various factors, including, but not limited to: (i) the composition of the board of directors of the Combined Company, (ii) the composition of senior management of the Combined Company, and (iii) the premium transferred to the Legacy HTA stockholders. As a result, the historical financial statements of the accounting acquirer, Legacy HR, became the historical financial statements of the Combined Company. The acquisition was accounted for using the acquisition method of accounting in accordance with ASC 805, which requires, among other things, the assets acquired and the liabilities assumed to be recognized at their acquisition date fair value. The consideration transferred on the Closing Date is as follows: Dollars in thousands Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (a) 228,520,990 Exchange ratio 1.00 Implied shares of Legacy HR Common Stock issued 228,520,990 Adjusted closing price of Legacy HR Common Stock on July 20, 2022 (b) $ 24.37 Value of implied Legacy HR Common Stock issued $ 5,569,057 Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services (c) 7,406 Consideration transferred $ 5,576,463 (a) Includes 228,520,990 shares of Legacy HTA Common Stock as of July 20, 2022. The number of shares of HTA Common Stock presented above was based on 228,857,717 total shares of Legacy HTA Common Stock outstanding as of the Closing Date, less 192 HTA fractional shares that were paid in cash less 336,535 shares of Legacy HTA restricted stock (net of 215,764 shares of Legacy HTA restricted stock withheld). For accounting purposes, these shares and units were converted to Legacy HR Common Stock, at an exchange ratio of 1.00 per share of HTA Common Stock. (b) For accounting purposes, the fair value of Legacy HR Common Stock issued to former holders of Legacy HTA Common Stock was based on the per share closing price of Legacy HR Common Stock on July 20, 2022. (c) Represents the fair value of Legacy HTA restricted shares which fully vested prior to the closing of the Merger or became fully vested as a result of the closing of the Merger and which are attributable to pre-combination services. Preliminary Purchase Price Allocation The following table summarizes the preliminary estimated fair values of the assets acquired and liabilities assumed at the Closing Date: Dollars in thousands ASSETS Real estate investments Land $ 985,926 Buildings and improvements 6,960,418 Lease intangible assets (a) 831,920 Financing lease right-of-use assets 9,874 Construction in progress 10,071 Land held for development 46,538 Total real estate investments $ 8,844,747 Assets held for sale, net 707,442 Investments in unconsolidated joint ventures 67,892 Cash and cash equivalents 26,034 Restricted cash 1,123,647 Operating lease right-of-use assets 198,261 Other assets, net (b) (c) 209,163 Total assets acquired $ 11,177,186 LIABILITIES Notes and bonds payable $ 3,991,300 Accounts payable and accrued liabilities 1,227,570 Liabilities of assets held for sale 28,677 Operating lease liabilities 173,948 Financing lease liabilities 10,720 Other liabilities 203,210 Total liabilities assumed $ 5,635,425 Net identifiable assets acquired $ 5,541,761 Non-controlling interest $ 110,702 Goodwill $ 145,404 (a) The weighted average amortization period for the acquired lease intangible assets is 5.5 years. (b) Includes $34.6 million of gross contractual accounts receivable, which approximates fair value, of which the Company preliminarily did not expect $12.3 million to be collected as of Closing Date. (c) Includes $78.7 million of gross contractual real estate notes receivable, the fair value of which was $74.8 million, and the Company preliminarily expects to collect substantially all of the real estate notes receivable proceeds as of the Closing Date. As of September 30, 2022, the Company had not finalized the determination of fair value of certain tangible and intangible assets acquired and liabilities assumed including, but not limited to real estate assets and liabilities, notes receivables and goodwill. As such, the assessment of fair value of assets acquired and liabilities assumed is preliminary and was based on information that was available at the time the Condensed Consolidated Financial Statements were prepared. The finalization of the purchase accounting assessment could result in material changes in the Company’s determination of the fair value of assets acquired and liabilities assumed, which will be recorded as measurement period adjustments in the period in which they are identified, up to one year from the Closing Date. A preliminary estimate of approximately $145.4 million has been allocated to goodwill. Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired and liabilities assumed. The recognized goodwill is attributable to expected synergies and benefits arising from the Merger, including anticipated general and administrative cost savings and potential economies of scale benefits in both tenant and vendor relationships following the closing of the Merger. None of the goodwill recognized is expected to be deductible for tax purposes. Merger related Costs In conjunction with the Merger, the Company incurred Merger-related costs of $79.4 million during the three months ended September 30, 2022 and $92.6 million during the nine months ended September 30, 2022, which were included within Merger-related costs in results of operations. The Merger-related costs primarily consist of legal, consulting, banking services, and other Merger-related costs. Unaudited Pro Forma Financial Information The Condensed Consolidated Statements of Income for the three months ended September 30, 2022 include $157.4 million of revenues and $20.6 million of net loss and for the nine months ended September 30, 2022 include $157.4 million of revenues and $20.6 million of net loss associated with the results of operations of Legacy HTA from the Merger closing date to September 30, 2022. The following unaudited pro forma information presents a summary of our Condensed Consolidated Statements of Income for the three months and nine months ended September 30, 2022 and 2021, as if the Merger had occurred on January 1, 2021. Adjustments in the pro forma financial information include but are not limited to the following: (i) additional depreciation and amortization expense related to the acquired tangible and intangible assets, (ii) additional interest expense on transaction-related borrowings, including assumed debt in connection with the Merger, (iii) additional rental income related to the assumed above and below-market leases, and straight-line rent and (iv) Merger-related costs and other one-time, non-recurring costs. The pro forma financial information excludes adjustments for estimated cost synergies or other effects of the integration of the Merger. The following pro forma financial information is not necessarily indicative of the results of operations had the acquisition been effected on the assumed date, nor is it necessarily an indication of trends in future results for a number of reasons, including, but not limited to, differences between the assumptions used to prepare the pro forma information, cost savings from operating efficiencies, potential synergies, and the impact of incremental costs incurred in integrating the businesses. THREE MONTHS ENDED NINE MONTHS ENDED Dollars in thousands 2022 2021 2022 2021 Total revenues $ 352,744 $ 332,465 $ 1,054,809 $ 982,192 Net income $ 115,496 $ (14,930) $ 160,120 $ (79,754)

Real Estate Investments

Real Estate Investments	9 Months Ended
	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Real Estate Investments	Real Estate Investments 2022 Company Acquisitions The following table details the Company's acquisitions for the nine months ended September 30, 2022: Dollars in thousands DATE ACQUIRED PURCHASE PRICE CASH 1 REAL ESTATE 2 OTHER 3 SQUARE FOOTAGE Dallas, TX 2/11/22 $ 8,175 $ 8,185 $ 8,202 $ (17) 18,000 San Francisco, CA 4 3/7/22 114,000 112,986 108,687 4,299 166,396 Q1 2022 subtotal 122,175 121,171 116,889 4,282 184,396 Atlanta, GA 4/7/22 6,912 7,054 7,178 (124) 21,535 Denver, CO 4/13/22 6,320 5,254 5,269 (15) 12,207 Colorado Springs, CO 5 4/13/22 13,680 13,686 13,701 (15) 25,800 Seattle, WA 4/28/22 8,350 8,334 8,370 (36) 13,256 Houston, TX 4/28/22 36,250 36,299 36,816 (517) 76,781 Los Angeles, CA 4/29/22 35,000 35,242 25,400 9,842 34,282 Oklahoma City, OK 4/29/22 11,100 11,259 11,334 (75) 34,944 Raleigh, NC 4 5/31/22 27,500 26,710 27,127 (417) 85,113 Tampa, FL 5 6/9/22 18,650 18,619 18,212 407 55,788 Q2 2022 subtotal 163,762 162,457 153,407 9,050 359,706 Seattle, WA 8/1/22 4,850 4,806 4,882 (76) 10,593 Raleigh, NC 8/9/22 3,783 3,878 3,932 (54) 11,345 Jacksonville, FL 8/9/22 18,195 18,508 18,583 (75) 34,133 Atlanta, GA 8/10/22 11,800 11,525 12,038 (513) 43,496 Denver, CO 8/11/22 14,800 13,902 13,918 (16) 34,785 Raleigh, NC 8/18/22 11,375 10,670 10,547 123 31,318 Nashville, TN 9/15/22 21,000 20,764 20,572 192 61,932 Austin, TX 9/29/22 5,450 5,449 5,572 (123) 15,000 Q3 2022 subtotal 91,253 89,502 90,044 (542) 242,602 Total real estate acquisitions $ 377,190 $ 373,130 $ 360,340 $ 12,790 786,704 1 Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. 2 Excludes financing right of use assets. 3 Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition. 4 Includes three properties. 5 Includes two properties. Subsequent to September 30, 2022, the Company acquired the following property: Dollars in thousands DATE ACQUIRED PURCHASE PRICE SQUARE FOOTAGE Jacksonville, FL 10/12/22 $ 3,600 6,200 2022 Joint Venture Acquisitions The following table details the joint venture acquisitions for the nine months ended September 30, 2022. These joint venture acquisitions are not consolidated for purposes of the Company's Condensed Consolidated Financial Statements. Dollars in thousands DATE ACQUIRED PURCHASE PRICE CASH 1 REAL OTHER 2 SQUARE FOOTAGE COMPANY OWNERSHIP % San Francisco, CA 3 3/7/22 $ 67,175 $ 66,789 $ 65,179 $ 1,610 110,865 50 % Los Angeles, CA 4 3/7/22 33,800 32,384 32,390 (6) 103,259 50 % Total joint venture acquisitions $ 100,975 $ 99,173 $ 97,569 $ 1,604 214,124 1 Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. 2 Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition. 3 Includes three properties. 4 Includes two properties. Unconsolidated Joint Ventures The Company's investment in and loss recognized for the three and nine months ended September 30, 2022 and 2021 related to its unconsolidated joint ventures accounted for under the equity method are shown in the table below: THREE MONTHS ENDED NINE MONTHS ENDED Dollars in thousands 2022 2021 2022 2021 Investments in unconsolidated joint ventures, beginning of period $ 210,781 $ 117,935 $ 161,942 $ 73,137 New investments during the period 1 117,880 4,593 167,479 49,612 Equity loss recognized during the period (124) (183) (776) (404) Owner distributions (785) — (893) — Investments in unconsolidated joint ventures, end of period 1 $ 327,752 $ 122,345 $ 327,752 $ 122,345 1 Includes unconsolidated joint ventures acquired as part of the Merger, as well as investments in two joint ventures representing a 20% and 40% ownership interest in portfolios in Los Angeles, California and Dallas, Texas, respectively. Also, see 2022 Real Estate Asset Dispositions below for additional information. 2022 Real Estate Asset Dispositions The following table details the Company's dispositions for the nine months ended September 30, 2022: Dollars in thousands DATE DISPOSED SALE PRICE CLOSING ADJUSTMENTS NET PROCEEDS NET REAL ESTATE INVESTMENT OTHER (INCLUDING RECEIVABLES) 1 GAIN/(IMPAIRMENT) SQUARE FOOTAGE Loveland, CO 2 2/24/22 $ 84,950 $ (45) $ 84,905 $ 40,095 $ 4 $ 44,806 150,291 San Antonio, TX 2 4/15/22 25,500 (2,272) 23,228 14,381 284 8,563 201,523 GA, FL, PA 3, 8 7/29/22 133,100 (8,109) 124,991 124,991 — — 316,739 GA, FL, TX 5, 8 8/4/22 160,917 (5,893) 155,024 151,819 3,205 — 343,545 Los Angeles, CA 3, 6, 8 8/5/22 134,845 (3,102) 131,743 131,332 411 — 283,780 Dallas, TX 5, 7, 8 8/30/22 114,290 (682) 113,608 113,608 — — 189,385 Indianapolis, IN 4, 9 8/31/22 238,845 (5,846) 232,999 84,767 4,324 143,908 506,406 Total dispositions $ 892,447 $ (25,949) $ 866,498 $ 660,993 $ 8,228 $ 197,277 1,991,669 1 Includes straight-line rent receivables, leasing commissions and lease inducements. 2 Includes two properties. 3 Includes four properties. 4 Includes five properties. 5 Includes six properties. 6 Values and square feet are represented at 100%. The Company retained a 20% ownership interest in the joint venture that purchased these properties. 7 Values and square feet are represented at 100%. The Company retained a 40% ownership interest in the joint venture that purchased these properties. 8 These properties were acquired as part of the Merger and were included as assets held for sale in the purchase price allocation. 9 Two of the five properties included in this portfolio were acquired in the Merger and were included as assets held for sale in the purchase price allocation. Subsequent to September 30, 2022, the Company disposed of the following properties: Dollars in thousands DATE DISPOSED SALE PRICE SQUARE FOOTAGE Dallas, TX 1, 2 10/4/22 $ 104,025 291,328 Houston, TX 2 10/21/22 32,000 134,910 Total dispositions $ 136,025 426,238 1 Includes two properties. 2 These properties were classified as assets held for sale as of September 30, 2022. Assets Held for Sale The Company had six properties classified as assets held for sale as of September 30, 2022 and no properties classified as assets held for sale as of December 31, 2021. The table below reflects the assets and liabilities of the properties classified as held for sale as of September 30, 2022 and December 31, 2021: Dollars in thousands September 30, 2022 December 31, 2021 Balance Sheet data: Land $ 10,594 $ — Building and improvements 199,821 — Lease intangibles 11,389 — Personal property 211 — Financing lease right-of-use assets 307 — 222,322 — Accumulated depreciation (47,051) — Real estate assets held for sale, net 175,271 — Operating lease right-of-use assets 1,193 — Other assets, net 8,610 57 Assets held for sale, net $ 185,074 $ 57 Accounts payable and accrued liabilities $ 3,768 $ 169 Operating lease liabilities $ 864 $ — Financing lease liabilities $ 2,427 $ — Other liabilities 3,585 125 Liabilities of assets held for sale $ 10,644 $ 294

Leases

Leases	9 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Leases	Leases Lessor Accounting The Company’s properties generally were leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2040. Some leases provide for fixed rent renewal terms in addition to market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company’s single-tenant net leases generally require the lessee to pay minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property. The Company's leases typically have escalators that are either based on a stated percentage or an index such as the consumer price index ("CPI"). In addition, most of the Company's leases include nonlease components, such as reimbursement of operating expenses as additional rent, or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the three and nine months ended September 30, 2022 was $298.9 million and $578.1 million, respectively. Lease income for the Company's operating leases recognized for the three and nine months ended September 30, 2021 was $131.7 million and $388.6 million, respectively. On March 30, 2022, the Company executed a lease as a ground lessor for a 1.9 acre parcel of land in Texas previously recorded in land held for development. The lease is classified as a sales-type lease under Topic 842 as the present value of lease payments equals or exceeds substantially all of the fair value of the underlying asset. The land value of $1.8 million was reclassified from Land held for development to Other assets. Future lease payments under the non-cancelable operating leases, excluding any reimbursements and the sale-type lease, as of September 30, 2022 were as follows: Dollars in thousands OPERATING 2022 $ 243,946 2023 937,733 2024 816,000 2025 702,251 2026 605,417 2027 and thereafter 2,242,792 $ 5,548,139 Lessee Accounting As of September 30, 2022, the Company was obligated, as the lessee, under operating lease agreements consisting primarily of the Company’s ground leases. As of September 30, 2022, the Company had 243 properties totaling 17.8 million square feet that were held under ground leases. Some of the ground lease renewal terms are based on fixed rent renewal terms and others have market rent renewal terms. These ground leases typically have initial terms of 40 to 99 years with expiration dates through 2119. Any rental increases related to the Company’s ground leases are generally either stated or based on CPI. The Company had 75 prepaid ground leases as of September 30, 2022. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $0.5 million and $0.1 million of the Company’s rental expense for the three months ended September 30, 2022 and 2021, respectively, and $0.8 million and $0.4 million for the nine months ended September 30, 2022 and 2021, respectively. The Company’s future lease payments (primarily for its 168 non-prepaid ground leases) as of September 30, 2022 were as follows: Dollars in thousands OPERATING FINANCING 2022 $ 3,665 $ 503 2023 15,606 2,139 2024 15,193 2,182 2025 14,715 2,218 2026 14,735 2,255 2027 and thereafter 894,018 398,092 Total undiscounted lease payments 957,932 407,389 Discount (689,092) (335,011) Lease liabilities $ 268,840 $ 72,378 The following table provides details of the Company's total lease expense for the three and nine months ended September 30, 2022 and 2021: THREE MONTHS ENDED NINE MONTHS ENDED Dollars in thousands 2022 2021 2022 2021 Operating lease cost Operating lease expense $ 4,204 $ 1,196 $ 6,613 $ 3,555 Variable lease expense 1,061 1,016 3,123 2,883 Finance lease cost Amortization of right-of-use assets 381 90 884 267 Interest on lease liabilities 861 255 1,913 748 Total lease expense $ 6,507 $ 2,557 $ 12,533 $ 7,453 Other information Operating cash flows outflows related to operating leases $ 3,847 $ 1,424 $ 8,443 $ 5,855 Operating cash flows outflows related to financing leases $ 476 $ 151 $ 1,262 $ 678 Financing cash flows outflows related to financing leases $ 3 $ 6 $ 3 $ 162 Right-of-use assets obtained in exchange for new finance lease liabilities $ 9,874 $ 1,420 $ 50,463 $ 1,420 Right-of-use assets obtained in exchange for new operating lease liabilities $ 198,261 $ 8,298 $ 198,261 $ 8,298 Weighted-average years remaining lease term (excluding renewal options) - operating leases 50.2 47.8 Weighted-average years remaining lease term (excluding renewal options) - finance leases 60.1 63.2 Weighted-average discount rate - operating leases 5.7 % 5.6 % Weighted-average discount rate - finance leases 5.0 % 5.4 %
Leases	Leases Lessor Accounting The Company’s properties generally were leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2040. Some leases provide for fixed rent renewal terms in addition to market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company’s single-tenant net leases generally require the lessee to pay minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property. The Company's leases typically have escalators that are either based on a stated percentage or an index such as the consumer price index ("CPI"). In addition, most of the Company's leases include nonlease components, such as reimbursement of operating expenses as additional rent, or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the three and nine months ended September 30, 2022 was $298.9 million and $578.1 million, respectively. Lease income for the Company's operating leases recognized for the three and nine months ended September 30, 2021 was $131.7 million and $388.6 million, respectively. On March 30, 2022, the Company executed a lease as a ground lessor for a 1.9 acre parcel of land in Texas previously recorded in land held for development. The lease is classified as a sales-type lease under Topic 842 as the present value of lease payments equals or exceeds substantially all of the fair value of the underlying asset. The land value of $1.8 million was reclassified from Land held for development to Other assets. Future lease payments under the non-cancelable operating leases, excluding any reimbursements and the sale-type lease, as of September 30, 2022 were as follows: Dollars in thousands OPERATING 2022 $ 243,946 2023 937,733 2024 816,000 2025 702,251 2026 605,417 2027 and thereafter 2,242,792 $ 5,548,139 Lessee Accounting As of September 30, 2022, the Company was obligated, as the lessee, under operating lease agreements consisting primarily of the Company’s ground leases. As of September 30, 2022, the Company had 243 properties totaling 17.8 million square feet that were held under ground leases. Some of the ground lease renewal terms are based on fixed rent renewal terms and others have market rent renewal terms. These ground leases typically have initial terms of 40 to 99 years with expiration dates through 2119. Any rental increases related to the Company’s ground leases are generally either stated or based on CPI. The Company had 75 prepaid ground leases as of September 30, 2022. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $0.5 million and $0.1 million of the Company’s rental expense for the three months ended September 30, 2022 and 2021, respectively, and $0.8 million and $0.4 million for the nine months ended September 30, 2022 and 2021, respectively. The Company’s future lease payments (primarily for its 168 non-prepaid ground leases) as of September 30, 2022 were as follows: Dollars in thousands OPERATING FINANCING 2022 $ 3,665 $ 503 2023 15,606 2,139 2024 15,193 2,182 2025 14,715 2,218 2026 14,735 2,255 2027 and thereafter 894,018 398,092 Total undiscounted lease payments 957,932 407,389 Discount (689,092) (335,011) Lease liabilities $ 268,840 $ 72,378 The following table provides details of the Company's total lease expense for the three and nine months ended September 30, 2022 and 2021: THREE MONTHS ENDED NINE MONTHS ENDED Dollars in thousands 2022 2021 2022 2021 Operating lease cost Operating lease expense $ 4,204 $ 1,196 $ 6,613 $ 3,555 Variable lease expense 1,061 1,016 3,123 2,883 Finance lease cost Amortization of right-of-use assets 381 90 884 267 Interest on lease liabilities 861 255 1,913 748 Total lease expense $ 6,507 $ 2,557 $ 12,533 $ 7,453 Other information Operating cash flows outflows related to operating leases $ 3,847 $ 1,424 $ 8,443 $ 5,855 Operating cash flows outflows related to financing leases $ 476 $ 151 $ 1,262 $ 678 Financing cash flows outflows related to financing leases $ 3 $ 6 $ 3 $ 162 Right-of-use assets obtained in exchange for new finance lease liabilities $ 9,874 $ 1,420 $ 50,463 $ 1,420 Right-of-use assets obtained in exchange for new operating lease liabilities $ 198,261 $ 8,298 $ 198,261 $ 8,298 Weighted-average years remaining lease term (excluding renewal options) - operating leases 50.2 47.8 Weighted-average years remaining lease term (excluding renewal options) - finance leases 60.1 63.2 Weighted-average discount rate - operating leases 5.7 % 5.6 % Weighted-average discount rate - finance leases 5.0 % 5.4 %

Other Assets and Liabilities

Other Assets and Liabilities	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Other Assets and Liabilities	Other Assets and Liabilities Other Assets Other assets consist primarily of intangible assets, prepaid assets, real estate notes receivable, straight-line rent receivables, accounts receivable, additional long-lived assets and interest rate swaps. Items included in "Other assets, net" on the Company's Condensed Consolidated Balance Sheets as of September 30, 2022 and December 31, 2021 are detailed in the table below: Dollars in thousands September 30, 2022 December 31, 2021 Above-market intangible assets, net $ 86,410 $ 4,966 Prepaid assets 85,053 58,618 Real estate notes receivable, net 1 79,036 — Straight-line rent receivables 78,038 70,784 Accounts receivable, net 36,103 14,072 Additional long-lived assets, net 21,722 20,048 Interest rate swap assets 16,136 — Ground lease modification, net 8,170 8,511 Other receivables, net 7,258 — Debt issuance costs, net 6,504 1,813 Project costs 4,001 5,129 Net investment in lease 1,828 — Customer relationship intangible assets, net 1,134 1,174 Other 6,842 558 $ 438,235 $ 185,673 1 In October 2022, an additional amount of $15.0 million was funded for a real estate loan transaction. Accounts Payable and Accrued Liabilities The following table provides details of the items included in "Accounts payable and accrued liabilities" on the Company's Condensed Consolidated Balance Sheets as of September 30, 2022 and December 31, 2021: Dollars in thousands September 30, 2022 December 31, 2021 Accrued property taxes $ 86,192 $ 35,295 Accounts payable and capital expenditures 61,461 17,036 Accrued interest 24,959 12,060 Accrued income and franchise taxes 2,685 983 Retainage accrued on construction invoices 1,304 2,215 Other operating accruals 54,417 18,519 $ 231,018 $ 86,108 Other Liabilities The following table provides details of the items included in "Other liabilities" on the Company's Condensed Consolidated Balance Sheets as of September 30, 2022 and December 31, 2021: Dollars in thousands September 30, 2022 December 31, 2021 Below-market intangible liabilities, net $ 113,118 $ 4,931 Deferred revenue 60,675 45,130 Security deposits 28,299 11,116 Interest rate swap liability — 5,917 Other 1,306 293 $ 203,398 $ 67,387

Notes and Bonds Payable

Notes and Bonds Payable	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Notes and Bonds Payable	Notes and Bonds Payable The table below details the Company’s notes and bonds payable as of September 30, 2022 and December 31, 2021. MATURITY DATES 1 BALANCE 2 AS OF EFFECTIVE INTEREST RATE Dollars in thousands 9/30/2022 12/31/2021 $1.5 billion Unsecured Credit Facility 3 10/27 $ 190,600 $ — 3.99 % $700 million Unsecured Credit Facility 3 5/23 — 210,000 — % $1.125 billion Asset Sale Term Loan 4 7/24 421,919 — 4.07 % $350 million Unsecured Term Loan 3 7/25 348,735 — 4.10 % $200 million Unsecured Term Loan 4 5/26 199,611 199,460 3.51 % $300 million Unsecured Term Loan 4 5 10/26 299,930 — 2.47 % $150 million Unsecured Term Loan 5 5/26 149,458 149,376 3.32 % $200 million Unsecured Term Loan 4 5 7/27 199,328 — 2.27 % $300 million Unsecured Term Loan 3 1/28 297,764 — 3.56 % Senior Notes due 2025 5/25 249,025 249,040 4.12 % Senior Notes due 2026 4 8/26 569,786 — 4.94 % Senior Notes due 2027 4 7/27 478,541 — 4.76 % Senior Notes due 2028 1/28 296,711 296,612 3.85 % Senior Notes due 2030 4 2/30 562,974 — 5.30 % Senior Notes due 2030 3/30 296,787 296,813 2.72 % Senior Notes due 2031 4 3/31 628,617 — 5.13 % Senior Notes due 2031 3/31 295,424 295,374 2.25 % Mortgage notes payable 8/23-12/26 84,929 104,650 3.97 % $ 5,570,139 $ 1,801,325 1 Includes extension options. 2 Balance is presented net of discounts and issuance costs and inclusive of premiums, where applicable. 3 On July 20, 2022, the Company entered into an amended and restated credit facility which included a $1.5 billion revolving credit facility, replacing Legacy HR's $700 million credit facility. 4 Debt instruments assumed as part of the Merger with Legacy HTA on July 20, 2022. Amounts shown represent fair value adjustments. 5 The effective interest rate includes the impact of interest rate swaps on $675.0 million at a weighted average rate of 1.57% (plus the applicable margin rate, currently 105 basis points). Changes in Debt Structure Mortgage payoffs On February 18, 2022, the Company repaid in full a mortgage note payable bearing interest at a rate of 4.70% that encumbered a 56,762 square foot property in California. The aggregate payoff price of $12.6 million consisted of outstanding principal of $11.0 million and a "make-whole" amount of approximately $1.6 million. The unamortized premium of $0.8 million and the unamortized cost on this note of $0.1 million were written off upon payoff. On February 24, 2022, the Company repaid in full a mortgage note payable bearing interest at a rate of 6.17% that encumbered a 80,153 square foot property in Colorado, in conjunction with the disposition of the property. The aggregate payoff price of $6.4 million consisted of outstanding principal of $5.8 million and a "make-whole" amount of approximately $0.6 million. The unamortized premium of $0.1 million was written off upon payoff. Exchange Offer In connection with the Merger, the OP offered to exchange all validly tendered and accepted notes of each series previously issued by Legacy HR (the “Old HR Notes”) for (i) up to $250,000,000 of 3.875% Senior Notes due 2025 (the “2025 Notes”), (ii) up to $300,000,000 of 3.625% Senior Notes due 2028 (the “2028 Notes”), (iii) up to $300,000,000 of 2.400% Senior Notes due 2030 (the “2030 Notes”) and (iv) up to $300,000,000 of 2.050% Senior Notes due 2031 to be issued by the OP (the “2031 Notes” and, collectively, the “New HR Notes”) and solicited consents from holders of the Old HR Notes to amend the indenture governing the Old HR Notes to eliminate substantially all of the restrictive covenants in such indenture (the “Exchange Offers”). The New HR Notes were issued pursuant to an indenture dated July 22, 2022, among the OP, Legacy HTA and U.S. Bank Trust Company, National Association, as trustee, as supplemented by the first supplemental indenture, dated as of July 22, 2022, the second supplemental indenture, dated as of July 22, 2022, the third supplemental indenture, dated as of July 22, 2022 and the fourth supplemental indenture, dated as of July 22, 2022. Legacy HTA guaranteed the New HR Notes pursuant to (i) a guarantee of the 2025 Notes, (ii) a guarantee of the 2028 Notes, (iii) a guarantee of the 2030 Notes, and (iv) a guarantee of the 2031 Notes, each dated July 22, 2022. Legacy HTA and the OP filed a registration statement on Form S-4 (File No. 333-265593) relating to the issuance of the New HR Notes with the Securities and Exchange Commission (the “SEC”) on June 14, 2022, which was declared effective by the SEC on June 28, 2022. The following sets forth the results of the Exchange Offers: Series of Old HR Notes Tenders and Consents Received as of the Expiration Date Percentage of Total Outstanding Principal Amount of Such Series of Old HR Notes 3.875 % Senior Notes due 2025 $235,016,000 94.01 % 3.625 % Senior Notes due 2028 $290,246,000 96.75 % 2.400 % Senior Notes due 2030 $297,507,000 99.17 % 2.050 % Senior Notes due 2031 $298,858,000 99.62 % Senior Notes Assumed with the Merger In connection with the Merger, the Company assumed senior notes ("Legacy Senior Notes") that were originated on various dates prior to the date of the Merger by the OP (formerly, Healthcare Trust of America Holdings, LP). These notes are all fully and unconditionally guaranteed by the Company and have semi-annual payment requirements. In addition, the Legacy Senior Notes carry customary restrictive financial covenants, including limitations on our ability to incur additional indebtedness and requirements to maintain a pool of unencumbered assets. In addition, the corresponding indentures provide for the ability to redeem the Legacy Senior Notes, subject to certain "make whole" call provisions. The Legacy Senior Notes assumed by the Company consist of the following: COUPON PRINCIPAL OUTSTANDING AS OF Dollars in thousands FACE VALUE 9/30/2022 12/31/2021 Senior Notes due 2026 3.50% $ 600,000 $ 600,000 $ — Senior Notes due 2027 3.75% 500,000 500,000 — Senior Notes due 2030 3.10% 650,000 650,000 — Senior Notes due 2031 2.00% 800,000 800,000 — $ 2,550,000 $ 2,550,000 $ — Credit Facilities In connection with the effectiveness of the Merger, Legacy HR (in a limited capacity), Legacy HTA and the OP entered into the Fourth Amended and Restated Credit and Term Loan Agreement (the “Credit Facility”) with Wells Fargo Bank, National Association, as Administrative Agent; Wells Fargo Securities, LLC, JPMorgan Chase Bank, N.A., and Citibank, N.A., as Joint Book Runners; Wells Fargo Securities, LLC, JPMorgan Chase Bank, N.A., U.S. Bank National Association, Citibank, N.A., The Bank of Nova Scotia, Capital One, National Association, U.S. Bank National Association, and PNC Capital Markets LLC, as Joint Lead Arrangers; and the other lenders named therein. The Credit Facility restructured the parties’ existing bank facilities and added additional borrowing capacities for the Company following the Merger. The OP is the borrower under the Credit Facility (in such capacity, the “Borrower”). • Legacy HR’s existing $700.0 million revolving credit facility under the Amended and Restated Credit Agreement, dated as of May 31, 2019 (as amended, restated, replaced, supplemented, or otherwise modified from time to time prior to July 20, 2022, the “Existing HR Revolving Credit Agreement”), by and among Legacy HR, the lenders party thereto from time to time and their assignees, as lenders, and Wells Fargo Bank, National Association, as the administrative agent (the “WF Administrative Agent”), was terminated, all outstanding obligations in respect thereof were deemed paid in full and all commitments thereunder were permanently reduced to zero and terminated. • Legacy HR’s existing $200.0 million term loan facility and existing $150.0 million term loan facility under the Amended and Restated Term Loan Agreement, dated as of May 31, 2019 (as amended, restated, replaced, supplemented, or otherwise modified from time to time prior to July 20, 2022, the “Existing HR Term Loan Agreement”), by and among Legacy HR, the lenders party thereto from time to time and their assignees, as lenders, and the WF Administrative Agent, in each, case, were deemed continued and assumed by the Borrower under the Credit Facility, and the Existing HR Term Loan Agreement was terminated. ◦ The existing $200.0 million term loan facility was amended to: (a) conform to the terms of the Borrower’s other term loan facilities under the Credit Facility; (b) include two one-year extension options, resulting in a latest final maturity in May 2026; and (c) reprice to align with the pricing for the Borrower’s other term loan facilities under the Credit Facility; and ◦ The existing $150.0 million term loan facility was amended to conform to the terms of the Borrower’s other term loan facilities under the Credit Facility, and the existing maturity in June 2026 remains unchanged under the Credit Facility. • Legacy HTA’s and the OP’s existing $1.0 billion revolving credit facility was upsized to $1.5 billion (the “Revolver”) pursuant to the Credit Facility. The Revolver currently matures in October 2025, and the Credit Facility adds an additional one-year extension option for the Revolver, for a total of two one-year extension options. • Legacy HTA’s and the OP’s existing $300.0 million term loan facility was deemed continued pursuant to the Credit Facility and was amended to conform to the terms of the Borrower’s other term loan facilities under the Credit Facility. The existing maturity in October 2025 remains unchanged under the Credit Facility. • Legacy HTA’s and the OP’s existing $200.0 million term loan facility was deemed continued pursuant to the Credit Facility and was amended to (a) conform to the terms of the Borrower’s other term loan facilities under the Credit Facility; (b) extend the maturity from January 2024 to July 20, 2027; and (c) reprice to align with the pricing for the Borrower’s other term loan facilities under the Credit Facility. • The Credit Facility provides for a new $350.0 million delayed-draw term loan facility that is available to be drawn for 12 months after July 20, 2022 and has an initial maturity date of July 20, 2023, with two one-year extension options. As of September 30, 2022, the $350.0 million Credit Facility was drawn in full. The terms of any delayed draw term loans funded thereunder conform to the terms of the Borrower’s other term loan facilities under the Credit Facility, and the pricing for such delayed draw term loans aligns with the pricing for the Borrower’s other term loan facilities under the Credit Facility. • The Credit Facility provides for a new $300.0 million term loan facility that was funded on July 20, 2022 and has a maturity date of January 20, 2028, with no extension options. The terms of such term loan facility conform to the terms of the Borrower’s other term loan facilities under the Credit Facility, and the pricing for such term loan facility aligns with the pricing for the Borrower’s other term loan facilities under the Credit Facility.

Derivative Financial Instrument

Derivative Financial Instruments	9 Months Ended
	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments Risk Management Objective of Using Derivatives The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s borrowings. Cash Flow Hedges of Interest Rate Risk The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt. For derivatives designated, and that qualify, as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income (Loss) ("AOCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings. Amounts reported in AOCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable-rate debt. As of September 30, 2022, the Company had 15 outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk: EXPIRATION DATE AMOUNT WEIGHTED December 16, 2022 75,000 2.37 % January 31, 2023 $ 300,000 1.42 % January 15, 2024 1 200,000 1.21 % May 1, 2026 1 100,000 2.15 % $ 675,000 1.57 % 1 Derivatives hedge one-month term SOFR. Subsequent to September 30, 2022, the Company entered into two additional interest rate swaps totaling $250.0 million with multiple counterparties, with both expiring in 2027. The Company designated these interest rate swaps as cash flow hedges of interest rate risk in the fourth quarter of 2022. Tabular Disclosure of Fair Values of Derivative Instruments on the Balance Sheet The table below presents the fair value of the Company's derivative financial instruments, as well as their classification on the Condensed Consolidated Balance Sheet as of September 30, 2022. BALANCE AT SEPTEMBER 30, 2022 In thousands BALANCE SHEET LOCATION FAIR VALUE Derivatives designated as hedging instruments Interest rate swaps Other assets $ 16,136 Tabular Disclosure of the Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss) The table below presents the effect of cash flow hedge accounting on AOCI during the three and nine months ended September 30, 2022 and 2021 related to the Company's outstanding interest rate swaps. GAIN RECOGNIZED IN LOSS RECLASSIFIED FROM In thousands 2022 2021 2022 2021 Interest rate swaps $ (6,083) $ (36) Interest expense $ 614 $ 982 Settled treasury hedges — — Interest expense 107 107 Settled interest rate swaps — — Interest expense 42 42 $ (6,083) $ (36) Total interest expense $ 763 $ 1,131 GAIN RECOGNIZED IN LOSS RECLASSIFIED FROM In thousands 2022 2021 2022 2021 Interest rate swaps $ (12,905) $ (2,079) Interest expense $ 2,226 $ 2,894 Settled treasury hedges — — Interest expense 320 320 Settled interest rate swaps — — Interest expense 126 126 $ (12,905) $ (2,079) Total interest expense $ 2,672 $ 3,340 The Company estimates that $4.8 million related to active interest rate swaps will be reclassified from AOCI as a decrease to interest expense over the next 12 months, and that $0.6 million related to settled interest rate swaps will be amortized from AOCI as an increase to interest expense over the next 12 months. Credit-risk-related Contingent Features The Company's agreements with each of its derivative counterparties contain a cross-default provision under which the Company could be declared in default of its derivative obligations if repayment of the underlying indebtedness is accelerated by the lender due to the Company's default on the indebtedness. As of September 30, 2022, the fair value of derivatives in a net asset position including accrued interest but excluding any adjustment for nonperformance risk related to these agreements was $16.5 million. As of September 30, 2022, the Company has not posted any collateral related to these agreements and was not in breach of any agreement.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Legal Proceedings The Company is, from time to time, involved in litigation arising in the ordinary course of business. The Company is not aware of any pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows. Development and Redevelopment Activity During the third quarter of 2022, the Company continued the redevelopment of a 217,114 square foot medical office building in Dallas, Texas. As of September 30, 2022, the Company had funded approximately $11.1 million in project costs. The building continues to operate with in-place leases during construction. The first new tenant lease of the redevelopment commenced in the first quarter of 2022. During the third quarter of 2022, the Company continued the redevelopment of a medical office building in Tacoma, Washington. As of September 30, 2022, the Company had funded approximately $10.3 million in project costs. The redevelopment includes interior and exterior improvements to the existing building, plus the addition of 23,000 square feet. The Company expects the 23,000 square foot tenant lease for the expansion space to commence in the fourth quarter of 2022. The Company continued the development of a medical office building in Nashville, Tennessee. The Company is constructing a new 106,194 square foot medical office building with the initial tenant lease expected to commence in the third quarter of 2023. As of September 30, 2022, the Company had funded approximately $15.3 million in project costs. The redevelopment includes the demolition of an existing 81,000 square foot medical office building. The Company recognized an impairment charge of $5.0 million related to the existing building in 2021. The Company is financing the construction of a two building medical office complex in Orlando, Florida. The 156,566 square foot development is expected to be complete in the second quarter of 2024. As of September 30, 2022, the Company had funded approximately $10.6 million towards the project costs. The Company, through a joint venture partnership, continued the development of a medical office building in Raleigh, North Carolina. This joint venture expects to construct a new 120,694 square foot medical office building that is projected to be complete in the fourth quarter of 2024. As of September 30, 2022, the joint venture had funded approximately $15.3 million towards the project costs. The Company is redeveloping three medical office buildings totaling 259,290 square feet in Washington, DC. The Company has approved a leasing plan with a capital outlay that is expected to be completed in the second quarter of

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Stockholders' Equity	Stockholders' Equity Common Stock The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the nine months ended September 30, 2022 and the twelve months ended December 31, 2021: NINE MONTHS ENDED SEPTEMBER 30, 2022 TWELVE MONTHS ENDED DECEMBER 31, 2021 Balance, beginning of period 150,457,433 139,487,375 Issuance of common stock 229,615,152 10,899,301 Non-vested share-based awards, net of withheld shares 499,705 70,757 Balance, end of period 380,572,290 150,457,433 At-The-Market Equity Offering Program The Company has equity distribution agreements with various sales agents with respect to the at-the-market (“ATM”) offering program of common stock with an aggregate sales amount of up to $750.0 million. As of September 30, 2022, $750.0 million remained available for issuance under our current ATM offering program. Common Stock Dividends During the nine months ended September 30, 2022, the Company declared and paid common stock dividends totaling $0.93 per share. On November 2, 2022, the Company declared a quarterly common stock dividend in the amount of $0.31 per share payable on November 30, 2022 to stockholders of record on November 15, 2022. Earnings Per Common Share The Company uses the two-class method of computing net earnings per common shares. The Company's non-vested share-based awards are considered participating securities pursuant to the two-class method. During the three and nine months ended September 30, 2022, the Company did not enter into any forward sale agreements to sell shares of common stock through the Company's ATM offering program. The following table sets forth the computation of basic and diluted earnings per common share for the three and nine months ended September 30, 2022 and 2021. THREE MONTHS ENDED SEPTEMBER 30, NINE MONTHS ENDED SEPTEMBER 30, Dollars in thousands, except per share data 2022 2021 2022 2021 Weighted average common shares outstanding Weighted average common shares outstanding 330,788,997 145,594,127 211,740,767 143,305,737 Non-vested shares (1,983,742) (1,776,508) (1,933,957) (1,784,544) Weighted average common shares outstanding - basic 328,805,255 143,817,619 209,806,810 141,521,193 Weighted average common shares outstanding - basic 328,805,255 143,817,619 209,806,810 141,521,193 Dilutive effect of forward equity shares — — — 14,036 Dilutive effect of OP Units 3,167,668 — 1,067,493 — Dilutive effect of employee stock purchase plan 58,461 — 69,687 78,200 Weighted average common shares outstanding - diluted 332,031,384 143,817,619 210,943,990 141,613,429 Net Income (loss) attributable to common stockholders $ 28,304 $ (2,066) $ 76,661 $ 45,052 Dividends paid on nonvested share-based awards (610) (537) (1,817) (1,617) Net income (loss) applicable to common stockholders- basic $ 27,694 $ (2,603) $ 74,844 $ 43,435 Net income attributable to OP units 312 — 312 — Net income (loss) applicable to common stockholders - diluted $ 28,006 $ (2,603) $ 75,156 $ 43,435 Basic earnings per common share - net income $ 0.08 $ (0.02) $ 0.36 $ 0.31 Diluted earnings per common share - net income $ 0.08 $ (0.02) $ 0.35 $ 0.31 The effect of non-vested stock awards totaling 911,594 shares, options under the Company's Employee Stock Purchase Plan (the "ESPP") to purchase the Company's stock totaling 63,383 shares, and the dilutive impact of forward-equity contracts outstanding for 14,734 shares of common stock for the three months ended September 30, 2021 were excluded from the calculation of diluted loss per common share because the effect was anti-dilutive due to the loss from continuing operations incurred during that period. Incentive Plans Restricted Common Shares During the nine months ended September 30, 2022, the Company made the following stock awards: • During the first quarter of 2022, the Company granted non-vested stock awards to its named executive officers and other members of senior management and employees with a grant date fair value of $13.0 million, which consisted of an aggregate of 415,184 non-vested shares with vesting periods ranging from three • During the second quarter of 2022, the Company granted non-vested stock awards to eight of its directors with a grant date fair value of $0.8 million, which consisted of an aggregate of 26,840 non-vested shares, with a one-year vesting period. • During the third quarter of 2022, the Company granted non-vested stock awards to its 12 non-employee directors with a grant date fair value of $1.8 million, which consisted of an aggregate of 70,816 non-vested shares, with vesting periods ranging from one A summary of the activity under the Company's share-based incentive plans for the three and nine months ended September 30, 2022 and 2021 is included in the table below. THREE MONTHS ENDED SEPTEMBER 30, NINE MONTHS ENDED SEPTEMBER 30, 2022 2021 2022 2021 Share-based awards, beginning of period 1,941,709 1,778,308 1,562,028 1,766,061 Granted 71,852 — 513,876 203,701 Vested (7,434) — (68,481) (191,454) Forfeited (4,130) (2,957) (5,426) (2,957) Share-based awards, end of period 2,001,997 1,775,351 2,001,997 1,775,351 During the nine months ended September 30, 2022 and 2021, the Company withheld 8,745 and 51,972 shares of common stock, respectively, from participants to pay estimated withholding taxes related to shares that vested. Restricted Stock Units Prior to 2022, the Company granted long-term incentive awards, comprised of restricted stock, based on backward-looking performance measured at the end of the calendar year. The Company adopted a new incentive compensation structure effective January 2022, comprised of restricted stock and restricted stock units ("RSUs"). The RSUs are granted at the beginning of the year with three-year forward-looking performance targets. On January 3, 2022, the Company granted RSUs to its named executive officers and certain other officers, with a grant date fair value of $9.7 million, which consisted of an aggregate 294,932 RSUs with a five-year vesting period. Approximately 43% of the RSUs vest based on two market performance conditions. Relative and absolute total shareholder return ("TSR") awards containing these market performance conditions were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair values of $30.56 for the absolute TSR component and $41.30 for the relative TSR component for the January 2022 grant using the following assumptions: THREE MONTHS ENDED MARCH 31, Volatility 30.0 % Dividend assumption Accrued Expected term 3 years Risk-free rate 1.02 % Stock price (per share) $31.68 The remaining 57% of the restricted stock units vest upon certain operating performance conditions. With respect to the operating performance conditions of the January grant, the grant date fair value was $31.68 based on the Company's share price on the date of grant. The combined weighted average grant date fair value of the January restricted stock units was $33.04 per share. The following is a summary of the RSU activity during the three and nine months ended September 30, 2022: THREE MONTHS ENDED SEPTEMBER 30, NINE MONTHS ENDED SEPTEMBER 30, Restricted Stock Units Weighted Average Grant Date Fair Value Restricted Stock Units Weighted Average Grant Date Fair Value Non-vested, beginning of period 294,932 — — — Granted — — 294,932 $ 33.04 Vested — — — — Non-vested as of September 30, 2022 294,932 294,932 Employee Stock Purchase Plan Legacy HR maintained an ESPP prior to the completion of the Merger. The outstanding options to purchase shares of the common stock of Legacy HR became options to purchase Class A Common Stock of the Company upon completion of the Merger. No new options will be granted under the ESPP. A summary of the activity under the ESPP for the three and nine months ended September 30, 2022 and 2021 is included in the table below. THREE MONTHS ENDED SEPTEMBER 30, NINE MONTHS ENDED SEPTEMBER 30, 2022 2021 2022 2021 Outstanding and exercisable, beginning of period 405,534 389,414 348,514 341,647 Granted — — 255,960 253,200 Exercised (4,576) (5,323) (17,094) (24,300) Forfeited (37,628) (18,961) (83,417) (60,995) Expired — — (140,633) (144,422) Outstanding and exercisable, end of period 363,330 365,130 363,330 365,130

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments The following methods and assumptions were used to estimate the fair value of each class of financial instrument for which it is practical to estimate that value. • Cash and cash equivalents - The carrying amount approximates fair value due to the short term maturity of these investments. • Real estate notes receivabl e - Real estate notes receivable are recorded in other assets on the Company's Condensed Consolidated Balance Sheets. Fair value is estimated using cash flow analyses, based on current interest rates for similar types of arrangements. • Borrowings under the Unsecured Credit Facility and the Term Loans Due 2024 and 2026 - The carrying amount approximates fair value because the borrowings are based on variable market interest rates. • Senior Notes and Mortgage Notes payable - The fair value of notes and bonds payable is estimated using cash flow analyses, based on the Company’s current interest rates for similar types of borrowing arrangements. • Interest rate swap agreements - Interest rate swap agreements are recorded in other liabilities on the Company's Condensed Consolidated Balance Sheets at fair value. Fair value is estimated by utilizing pricing models that consider forward yield curves and discount rates. The table below details the fair values and carrying values for notes and bonds payable and real estate notes receivable at September 30, 2022 and December 31, 2021. September 30, 2022 December 31, 2021 Dollars in millions CARRYING VALUE FAIR VALUE CARRYING VALUE FAIR VALUE Notes and bonds payable 1 $ 5,570.1 $ 5,321.0 $ 1,801.3 $ 1,797.4 Real estate notes receivable 1 $ 79.0 $ 79.0 $ — $ — 1 Level 2 – model-derived valuations in which significant inputs and significant value drivers are observable in active markets.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Business overview	Business OverviewHealthcare Realty Trust Incorporated is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of September 30, 2022, the Company had gross investments of approximately $14.2 billion in 695 real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development and corporate property. The Company's 695 real estate properties are located in 35 states and total approximately 40.7 million square feet. The Company provided leasing and property management services to approximately 38.9 million square feet nationwide. As of September 30, 2022, the Company had a weighted average ownership interest of approximately 49% in 33 real estate properties held in joint ventures. See Note 3 below for more details regarding the Company's unconsolidated joint ventures. Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the Company's Condensed Consolidated Financial Statements, are outside the scope of our independent registered public accounting firm’s review.
Basis of presentation	Basis of Presentation For purposes of this Quarterly Report on Form 10-Q, references to the “Company” are to Legacy HR for periods prior to the closing of the Merger and thereafter to Legacy HR and Legacy HTA after giving effect to the Merger. The Merger is described in more detail in Note 2 to these Condensed Consolidated Financial Statements. The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. However, except as disclosed herein and specific disclosures incorporated as a result of the Merger, management believes there has been no material change in the information disclosed in the Notes to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2021. All material intercompany transactions and balances have been eliminated in consolidation. This interim financial information should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. In addition, the interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2022 for many reasons including, but not limited to, the Merger (as discussed in more detail in Note 2 below), acquisitions, dispositions, capital financing transactions, changes in interest rates and the effects of other trends, risks and uncertainties.
Principles of consolidation	Principles of ConsolidationThe Company’s Condensed Consolidated Financial Statements include, as of September 30, 2022, the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities.
Variable Interest Entities	GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (“VIEs”). Accounting Standards Codification 810 broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity’s economic performance or (ii) the equity investment at risk is insufficient to finance that entity’s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact the entity’s economic performance; and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE’s primary beneficiary. The Company may change its original assessment of a VIE upon subsequent events such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity’s equity investments at risk and the disposition of all or a portion of an interest held by the primary beneficiary. The Company performs this analysis on an ongoing basis. As of September 30, 2022, the Company identified three entities that qualified as VIE's because the limited partners in these partnerships, although entitled to vote on certain matters, do not possess kick-out rights or substantive participating rights. Two of the entities are consolidated and one is unconsolidated. Holders of operating partnership units (“OP Units”) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Condensed Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of September 30, 2022, there were approximately 4.0 million, or 1.1%, of OP Units issued and outstanding held by non-controlling interest holders. Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates the interests in the OP. However, because the Company holds what is deemed to be significantly all of the OP, it qualifies for the exemption from providing certain disclosure requirements associated with investments in VIEs. For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation.
Use of estimates in the condensed consolidated financial statements	Use of Estimates in the Condensed Consolidated Financial Statements Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates.
Reclassifications	Reclassifications Certain reclassifications have been made on the Company's prior year Condensed Consolidated Balance Sheet to conform to current year presentation. Previously, the Company's Lease intangibles were included in Building, improvements and lease intangibles and Goodwill was included with Other assets, net. These amounts are now classified as separate line items on the Company's Condensed Consolidated Balance Sheets.
Investments in Leases - Financing Receivables, Net	Investments in Leases - Financing Receivables, Net In accordance with Accounting Standards Codification ("ASC") 842, for transactions in which the Company enters into a contract to acquire an asset and leases it back to the seller (i.e., a sale leaseback transaction), control of the asset is not considered to have transferred when the seller-lessee has a purchase option. As a result, the Company does not recognize the underlying real estate asset but instead recognizes a financial asset in accordance with ASC 310 “Receivables”. During the first quarter of 2022, the Company reclassified the two medical office buildings in Nashville, Tennessee that were acquired in separate sale-leaseback transactions in the fourth quarter of 2021. The leases with the sellers commenced in the first quarter, which resulted in the allocation of the financing receivable totaling $73.9 million to land and building and improvements. Real Estate Notes Receivable Real estate notes receivable consists of mezzanine and other real estate loans, which are generally collateralized by a pledge of the borrower’s ownership interest in the respective real estate owner, a mortgage or deed of trust, and/or corporate guarantees. Real estate notes receivable are intended to be held-to-maturity and are recorded at amortized cost, net of unamortized loan origination costs and fees and allowance for credit losses. As of September 30, 2022, real estate notes receivable, net totaled $79.0 million. Interest Income Income from Lease Financing Receivables For the three and nine months ended September 30, 2022, the Company recognized the related income from two financing receivables totaling $2.0 million and $5.9 million, respectively, based on an imputed interest rate over the terms of the applicable lease. As a result, the interest recognized from the financing receivable will not equal the cash payments from the lease agreement. Acquisition costs incurred in connection with entering into the financing receivable are treated as loan origination fees. These costs are classified with the financing receivable and are included in the balance of the net investment. Amortization of these amounts will be recognized as a reduction to Income from financing receivable, net over the life of the lease. Income from Real Estate Notes Receivable
Revenue from contract with customers (topic 606)	Revenue from Contracts with Customers (Topic 606) The Company recognizes certain revenue under the core principle of Topic 606. This topic requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of Topic 606. To achieve the core principle, the Company applies the five step model specified in the guidance.
New accounting pronouncements	New Accounting Pronouncements Accounting Standards Update No. 2020-04 On March 12, 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-04, Reference Rate Reform (Topic 848)

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Disaggregation of revenue	Below is a detail of the amounts by category: THREE MONTHS ENDED NINE MONTHS ENDED in thousands 2022 2021 2022 2021 Type of Revenue Parking income $ 2,428 $ 2,187 $ 6,100 $ 5,725 Management fee income 1 1,426 723 2,864 1,381 Miscellaneous 203 59 306 241 $ 4,057 $ 2,969 $ 9,270 $ 7,347

Merger with HTA (Tables)

Merger with HTA (Tables)	9 Months Ended
	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of Consideration Transferred	The consideration transferred on the Closing Date is as follows: Dollars in thousands Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (a) 228,520,990 Exchange ratio 1.00 Implied shares of Legacy HR Common Stock issued 228,520,990 Adjusted closing price of Legacy HR Common Stock on July 20, 2022 (b) $ 24.37 Value of implied Legacy HR Common Stock issued $ 5,569,057 Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services (c) 7,406 Consideration transferred $ 5,576,463 (a) Includes 228,520,990 shares of Legacy HTA Common Stock as of July 20, 2022. The number of shares of HTA Common Stock presented above was based on 228,857,717 total shares of Legacy HTA Common Stock outstanding as of the Closing Date, less 192 HTA fractional shares that were paid in cash less 336,535 shares of Legacy HTA restricted stock (net of 215,764 shares of Legacy HTA restricted stock withheld). For accounting purposes, these shares and units were converted to Legacy HR Common Stock, at an exchange ratio of 1.00 per share of HTA Common Stock. (b) For accounting purposes, the fair value of Legacy HR Common Stock issued to former holders of Legacy HTA Common Stock was based on the per share closing price of Legacy HR Common Stock on July 20, 2022.
Schedule of Fair Values of the Assets Acquired And Liabilities Assumed	The following table summarizes the preliminary estimated fair values of the assets acquired and liabilities assumed at the Closing Date: Dollars in thousands ASSETS Real estate investments Land $ 985,926 Buildings and improvements 6,960,418 Lease intangible assets (a) 831,920 Financing lease right-of-use assets 9,874 Construction in progress 10,071 Land held for development 46,538 Total real estate investments $ 8,844,747 Assets held for sale, net 707,442 Investments in unconsolidated joint ventures 67,892 Cash and cash equivalents 26,034 Restricted cash 1,123,647 Operating lease right-of-use assets 198,261 Other assets, net (b) (c) 209,163 Total assets acquired $ 11,177,186 LIABILITIES Notes and bonds payable $ 3,991,300 Accounts payable and accrued liabilities 1,227,570 Liabilities of assets held for sale 28,677 Operating lease liabilities 173,948 Financing lease liabilities 10,720 Other liabilities 203,210 Total liabilities assumed $ 5,635,425 Net identifiable assets acquired $ 5,541,761 Non-controlling interest $ 110,702 Goodwill $ 145,404 (a) The weighted average amortization period for the acquired lease intangible assets is 5.5 years. (b) Includes $34.6 million of gross contractual accounts receivable, which approximates fair value, of which the Company preliminarily did not expect $12.3 million to be collected as of Closing Date. (c) Includes $78.7 million of gross contractual real estate notes receivable, the fair value of which was $74.8 million, and the Company preliminarily expects to collect substantially all of the real estate notes receivable proceeds as of the Closing Date.
Schedule of Business Acquisition, Pro Forma Information	The following pro forma financial information is not necessarily indicative of the results of operations had the acquisition been effected on the assumed date, nor is it necessarily an indication of trends in future results for a number of reasons, including, but not limited to, differences between the assumptions used to prepare the pro forma information, cost savings from operating efficiencies, potential synergies, and the impact of incremental costs incurred in integrating the businesses. THREE MONTHS ENDED NINE MONTHS ENDED Dollars in thousands 2022 2021 2022 2021 Total revenues $ 352,744 $ 332,465 $ 1,054,809 $ 982,192 Net income $ 115,496 $ (14,930) $ 160,120 $ (79,754)

Real Estate Investments (Tables

Real Estate Investments (Tables)	9 Months Ended
	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Summary of Acquisitions	The following table details the Company's acquisitions for the nine months ended September 30, 2022: Dollars in thousands DATE ACQUIRED PURCHASE PRICE CASH 1 REAL ESTATE 2 OTHER 3 SQUARE FOOTAGE Dallas, TX 2/11/22 $ 8,175 $ 8,185 $ 8,202 $ (17) 18,000 San Francisco, CA 4 3/7/22 114,000 112,986 108,687 4,299 166,396 Q1 2022 subtotal 122,175 121,171 116,889 4,282 184,396 Atlanta, GA 4/7/22 6,912 7,054 7,178 (124) 21,535 Denver, CO 4/13/22 6,320 5,254 5,269 (15) 12,207 Colorado Springs, CO 5 4/13/22 13,680 13,686 13,701 (15) 25,800 Seattle, WA 4/28/22 8,350 8,334 8,370 (36) 13,256 Houston, TX 4/28/22 36,250 36,299 36,816 (517) 76,781 Los Angeles, CA 4/29/22 35,000 35,242 25,400 9,842 34,282 Oklahoma City, OK 4/29/22 11,100 11,259 11,334 (75) 34,944 Raleigh, NC 4 5/31/22 27,500 26,710 27,127 (417) 85,113 Tampa, FL 5 6/9/22 18,650 18,619 18,212 407 55,788 Q2 2022 subtotal 163,762 162,457 153,407 9,050 359,706 Seattle, WA 8/1/22 4,850 4,806 4,882 (76) 10,593 Raleigh, NC 8/9/22 3,783 3,878 3,932 (54) 11,345 Jacksonville, FL 8/9/22 18,195 18,508 18,583 (75) 34,133 Atlanta, GA 8/10/22 11,800 11,525 12,038 (513) 43,496 Denver, CO 8/11/22 14,800 13,902 13,918 (16) 34,785 Raleigh, NC 8/18/22 11,375 10,670 10,547 123 31,318 Nashville, TN 9/15/22 21,000 20,764 20,572 192 61,932 Austin, TX 9/29/22 5,450 5,449 5,572 (123) 15,000 Q3 2022 subtotal 91,253 89,502 90,044 (542) 242,602 Total real estate acquisitions $ 377,190 $ 373,130 $ 360,340 $ 12,790 786,704 1 Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. 2 Excludes financing right of use assets. 3 Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition. 4 Includes three properties. 5 Includes two properties. Subsequent to September 30, 2022, the Company acquired the following property: Dollars in thousands DATE ACQUIRED PURCHASE PRICE SQUARE FOOTAGE Jacksonville, FL 10/12/22 $ 3,600 6,200
Schedule of joint venture transactions	The following table details the joint venture acquisitions for the nine months ended September 30, 2022. These joint venture acquisitions are not consolidated for purposes of the Company's Condensed Consolidated Financial Statements. Dollars in thousands DATE ACQUIRED PURCHASE PRICE CASH 1 REAL OTHER 2 SQUARE FOOTAGE COMPANY OWNERSHIP % San Francisco, CA 3 3/7/22 $ 67,175 $ 66,789 $ 65,179 $ 1,610 110,865 50 % Los Angeles, CA 4 3/7/22 33,800 32,384 32,390 (6) 103,259 50 % Total joint venture acquisitions $ 100,975 $ 99,173 $ 97,569 $ 1,604 214,124 1 Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. 2 Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition. 3 Includes three properties. 4 Includes two properties.
Schedule of equity method investments	The Company's investment in and loss recognized for the three and nine months ended September 30, 2022 and 2021 related to its unconsolidated joint ventures accounted for under the equity method are shown in the table below: THREE MONTHS ENDED NINE MONTHS ENDED Dollars in thousands 2022 2021 2022 2021 Investments in unconsolidated joint ventures, beginning of period $ 210,781 $ 117,935 $ 161,942 $ 73,137 New investments during the period 1 117,880 4,593 167,479 49,612 Equity loss recognized during the period (124) (183) (776) (404) Owner distributions (785) — (893) — Investments in unconsolidated joint ventures, end of period 1 $ 327,752 $ 122,345 $ 327,752 $ 122,345 1 Includes unconsolidated joint ventures acquired as part of the Merger, as well as investments in two joint ventures representing a 20% and 40% ownership interest in portfolios in Los Angeles, California and Dallas, Texas, respectively. Also, see 2022 Real Estate Asset Dispositions below for additional information.
Real estate dispositions	The following table details the Company's dispositions for the nine months ended September 30, 2022: Dollars in thousands DATE DISPOSED SALE PRICE CLOSING ADJUSTMENTS NET PROCEEDS NET REAL ESTATE INVESTMENT OTHER (INCLUDING RECEIVABLES) 1 GAIN/(IMPAIRMENT) SQUARE FOOTAGE Loveland, CO 2 2/24/22 $ 84,950 $ (45) $ 84,905 $ 40,095 $ 4 $ 44,806 150,291 San Antonio, TX 2 4/15/22 25,500 (2,272) 23,228 14,381 284 8,563 201,523 GA, FL, PA 3, 8 7/29/22 133,100 (8,109) 124,991 124,991 — — 316,739 GA, FL, TX 5, 8 8/4/22 160,917 (5,893) 155,024 151,819 3,205 — 343,545 Los Angeles, CA 3, 6, 8 8/5/22 134,845 (3,102) 131,743 131,332 411 — 283,780 Dallas, TX 5, 7, 8 8/30/22 114,290 (682) 113,608 113,608 — — 189,385 Indianapolis, IN 4, 9 8/31/22 238,845 (5,846) 232,999 84,767 4,324 143,908 506,406 Total dispositions $ 892,447 $ (25,949) $ 866,498 $ 660,993 $ 8,228 $ 197,277 1,991,669 1 Includes straight-line rent receivables, leasing commissions and lease inducements. 2 Includes two properties. 3 Includes four properties. 4 Includes five properties. 5 Includes six properties. 6 Values and square feet are represented at 100%. The Company retained a 20% ownership interest in the joint venture that purchased these properties. 7 Values and square feet are represented at 100%. The Company retained a 40% ownership interest in the joint venture that purchased these properties. 8 These properties were acquired as part of the Merger and were included as assets held for sale in the purchase price allocation. 9 Two of the five properties included in this portfolio were acquired in the Merger and were included as assets held for sale in the purchase price allocation. Subsequent to September 30, 2022, the Company disposed of the following properties: Dollars in thousands DATE DISPOSED SALE PRICE SQUARE FOOTAGE Dallas, TX 1, 2 10/4/22 $ 104,025 291,328 Houston, TX 2 10/21/22 32,000 134,910 Total dispositions $ 136,025 426,238 1 Includes two properties. 2 These properties were classified as assets held for sale as of September 30, 2022.
Schedule of assets and liabilities held for sale	The table below reflects the assets and liabilities of the properties classified as held for sale as of September 30, 2022 and December 31, 2021: Dollars in thousands September 30, 2022 December 31, 2021 Balance Sheet data: Land $ 10,594 $ — Building and improvements 199,821 — Lease intangibles 11,389 — Personal property 211 — Financing lease right-of-use assets 307 — 222,322 — Accumulated depreciation (47,051) — Real estate assets held for sale, net 175,271 — Operating lease right-of-use assets 1,193 — Other assets, net 8,610 57 Assets held for sale, net $ 185,074 $ 57 Accounts payable and accrued liabilities $ 3,768 $ 169 Operating lease liabilities $ 864 $ — Financing lease liabilities $ 2,427 $ — Other liabilities 3,585 125 Liabilities of assets held for sale $ 10,644 $ 294

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Future Minimum Operating Lease Payments Receivable	Future lease payments under the non-cancelable operating leases, excluding any reimbursements and the sale-type lease, as of September 30, 2022 were as follows: Dollars in thousands OPERATING 2022 $ 243,946 2023 937,733 2024 816,000 2025 702,251 2026 605,417 2027 and thereafter 2,242,792 $ 5,548,139
Future Minimum Operating Lease Payments	The Company’s future lease payments (primarily for its 168 non-prepaid ground leases) as of September 30, 2022 were as follows: Dollars in thousands OPERATING FINANCING 2022 $ 3,665 $ 503 2023 15,606 2,139 2024 15,193 2,182 2025 14,715 2,218 2026 14,735 2,255 2027 and thereafter 894,018 398,092 Total undiscounted lease payments 957,932 407,389 Discount (689,092) (335,011) Lease liabilities $ 268,840 $ 72,378
Future Minimum Financing Lease Payments	The Company’s future lease payments (primarily for its 168 non-prepaid ground leases) as of September 30, 2022 were as follows: Dollars in thousands OPERATING FINANCING 2022 $ 3,665 $ 503 2023 15,606 2,139 2024 15,193 2,182 2025 14,715 2,218 2026 14,735 2,255 2027 and thereafter 894,018 398,092 Total undiscounted lease payments 957,932 407,389 Discount (689,092) (335,011) Lease liabilities $ 268,840 $ 72,378
Lease Cost	The following table provides details of the Company's total lease expense for the three and nine months ended September 30, 2022 and 2021: THREE MONTHS ENDED NINE MONTHS ENDED Dollars in thousands 2022 2021 2022 2021 Operating lease cost Operating lease expense $ 4,204 $ 1,196 $ 6,613 $ 3,555 Variable lease expense 1,061 1,016 3,123 2,883 Finance lease cost Amortization of right-of-use assets 381 90 884 267 Interest on lease liabilities 861 255 1,913 748 Total lease expense $ 6,507 $ 2,557 $ 12,533 $ 7,453 Other information Operating cash flows outflows related to operating leases $ 3,847 $ 1,424 $ 8,443 $ 5,855 Operating cash flows outflows related to financing leases $ 476 $ 151 $ 1,262 $ 678 Financing cash flows outflows related to financing leases $ 3 $ 6 $ 3 $ 162 Right-of-use assets obtained in exchange for new finance lease liabilities $ 9,874 $ 1,420 $ 50,463 $ 1,420 Right-of-use assets obtained in exchange for new operating lease liabilities $ 198,261 $ 8,298 $ 198,261 $ 8,298 Weighted-average years remaining lease term (excluding renewal options) - operating leases 50.2 47.8 Weighted-average years remaining lease term (excluding renewal options) - finance leases 60.1 63.2 Weighted-average discount rate - operating leases 5.7 % 5.6 % Weighted-average discount rate - finance leases 5.0 % 5.4 %

Other Assets and Liabilities (T

Other Assets and Liabilities (Tables)	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Other Assets	Other assets consist primarily of intangible assets, prepaid assets, real estate notes receivable, straight-line rent receivables, accounts receivable, additional long-lived assets and interest rate swaps. Items included in "Other assets, net" on the Company's Condensed Consolidated Balance Sheets as of September 30, 2022 and December 31, 2021 are detailed in the table below: Dollars in thousands September 30, 2022 December 31, 2021 Above-market intangible assets, net $ 86,410 $ 4,966 Prepaid assets 85,053 58,618 Real estate notes receivable, net 1 79,036 — Straight-line rent receivables 78,038 70,784 Accounts receivable, net 36,103 14,072 Additional long-lived assets, net 21,722 20,048 Interest rate swap assets 16,136 — Ground lease modification, net 8,170 8,511 Other receivables, net 7,258 — Debt issuance costs, net 6,504 1,813 Project costs 4,001 5,129 Net investment in lease 1,828 — Customer relationship intangible assets, net 1,134 1,174 Other 6,842 558 $ 438,235 $ 185,673 1 In October 2022, an additional amount of $15.0 million was funded for a real estate loan transaction.
Schedule of Accounts Payable and Accrued Liabilities	The following table provides details of the items included in "Accounts payable and accrued liabilities" on the Company's Condensed Consolidated Balance Sheets as of September 30, 2022 and December 31, 2021: Dollars in thousands September 30, 2022 December 31, 2021 Accrued property taxes $ 86,192 $ 35,295 Accounts payable and capital expenditures 61,461 17,036 Accrued interest 24,959 12,060 Accrued income and franchise taxes 2,685 983 Retainage accrued on construction invoices 1,304 2,215 Other operating accruals 54,417 18,519 $ 231,018 $ 86,108
Schedule of Other Liabilities	The following table provides details of the items included in "Other liabilities" on the Company's Condensed Consolidated Balance Sheets as of September 30, 2022 and December 31, 2021: Dollars in thousands September 30, 2022 December 31, 2021 Below-market intangible liabilities, net $ 113,118 $ 4,931 Deferred revenue 60,675 45,130 Security deposits 28,299 11,116 Interest rate swap liability — 5,917 Other 1,306 293 $ 203,398 $ 67,387

Notes and Bonds Payable (Tables

Notes and Bonds Payable (Tables)	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Schedule of debt	The table below details the Company’s notes and bonds payable as of September 30, 2022 and December 31, 2021. MATURITY DATES 1 BALANCE 2 AS OF EFFECTIVE INTEREST RATE Dollars in thousands 9/30/2022 12/31/2021 $1.5 billion Unsecured Credit Facility 3 10/27 $ 190,600 $ — 3.99 % $700 million Unsecured Credit Facility 3 5/23 — 210,000 — % $1.125 billion Asset Sale Term Loan 4 7/24 421,919 — 4.07 % $350 million Unsecured Term Loan 3 7/25 348,735 — 4.10 % $200 million Unsecured Term Loan 4 5/26 199,611 199,460 3.51 % $300 million Unsecured Term Loan 4 5 10/26 299,930 — 2.47 % $150 million Unsecured Term Loan 5 5/26 149,458 149,376 3.32 % $200 million Unsecured Term Loan 4 5 7/27 199,328 — 2.27 % $300 million Unsecured Term Loan 3 1/28 297,764 — 3.56 % Senior Notes due 2025 5/25 249,025 249,040 4.12 % Senior Notes due 2026 4 8/26 569,786 — 4.94 % Senior Notes due 2027 4 7/27 478,541 — 4.76 % Senior Notes due 2028 1/28 296,711 296,612 3.85 % Senior Notes due 2030 4 2/30 562,974 — 5.30 % Senior Notes due 2030 3/30 296,787 296,813 2.72 % Senior Notes due 2031 4 3/31 628,617 — 5.13 % Senior Notes due 2031 3/31 295,424 295,374 2.25 % Mortgage notes payable 8/23-12/26 84,929 104,650 3.97 % $ 5,570,139 $ 1,801,325 1 Includes extension options. 2 Balance is presented net of discounts and issuance costs and inclusive of premiums, where applicable. 3 On July 20, 2022, the Company entered into an amended and restated credit facility which included a $1.5 billion revolving credit facility, replacing Legacy HR's $700 million credit facility. 4 Debt instruments assumed as part of the Merger with Legacy HTA on July 20, 2022. Amounts shown represent fair value adjustments. 5 The effective interest rate includes the impact of interest rate swaps on $675.0 million at a weighted average rate of 1.57% (plus the applicable margin rate, currently 105 basis points).
Schedule of Debt Exchange Offers	The following sets forth the results of the Exchange Offers: Series of Old HR Notes Tenders and Consents Received as of the Expiration Date Percentage of Total Outstanding Principal Amount of Such Series of Old HR Notes 3.875 % Senior Notes due 2025 $235,016,000 94.01 % 3.625 % Senior Notes due 2028 $290,246,000 96.75 % 2.400 % Senior Notes due 2030 $297,507,000 99.17 % 2.050 % Senior Notes due 2031 $298,858,000 99.62 %
Schedule of Senior Notes Assumed with the Merger	The Legacy Senior Notes assumed by the Company consist of the following: COUPON PRINCIPAL OUTSTANDING AS OF Dollars in thousands FACE VALUE 9/30/2022 12/31/2021 Senior Notes due 2026 3.50% $ 600,000 $ 600,000 $ — Senior Notes due 2027 3.75% 500,000 500,000 — Senior Notes due 2030 3.10% 650,000 650,000 — Senior Notes due 2031 2.00% 800,000 800,000 — $ 2,550,000 $ 2,550,000 $ —

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of cash flow hedges included in accumulated other comprehensive income (loss)	As of September 30, 2022, the Company had 15 outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk: EXPIRATION DATE AMOUNT WEIGHTED December 16, 2022 75,000 2.37 % January 31, 2023 $ 300,000 1.42 % January 15, 2024 1 200,000 1.21 % May 1, 2026 1 100,000 2.15 % $ 675,000 1.57 % 1 Derivatives hedge one-month term SOFR. The table below presents the effect of cash flow hedge accounting on AOCI during the three and nine months ended September 30, 2022 and 2021 related to the Company's outstanding interest rate swaps. GAIN RECOGNIZED IN LOSS RECLASSIFIED FROM In thousands 2022 2021 2022 2021 Interest rate swaps $ (6,083) $ (36) Interest expense $ 614 $ 982 Settled treasury hedges — — Interest expense 107 107 Settled interest rate swaps — — Interest expense 42 42 $ (6,083) $ (36) Total interest expense $ 763 $ 1,131 GAIN RECOGNIZED IN LOSS RECLASSIFIED FROM In thousands 2022 2021 2022 2021 Interest rate swaps $ (12,905) $ (2,079) Interest expense $ 2,226 $ 2,894 Settled treasury hedges — — Interest expense 320 320 Settled interest rate swaps — — Interest expense 126 126 $ (12,905) $ (2,079) Total interest expense $ 2,672 $ 3,340
Schedule of derivative instruments in statement of financial position, fair value	The table below presents the fair value of the Company's derivative financial instruments, as well as their classification on the Condensed Consolidated Balance Sheet as of September 30, 2022. BALANCE AT SEPTEMBER 30, 2022 In thousands BALANCE SHEET LOCATION FAIR VALUE Derivatives designated as hedging instruments Interest rate swaps Other assets $ 16,136

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Reconciliation of common stock outstanding	The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the nine months ended September 30, 2022 and the twelve months ended December 31, 2021: NINE MONTHS ENDED SEPTEMBER 30, 2022 TWELVE MONTHS ENDED DECEMBER 31, 2021 Balance, beginning of period 150,457,433 139,487,375 Issuance of common stock 229,615,152 10,899,301 Non-vested share-based awards, net of withheld shares 499,705 70,757 Balance, end of period 380,572,290 150,457,433
Earnings (loss) per share	The following table sets forth the computation of basic and diluted earnings per common share for the three and nine months ended September 30, 2022 and 2021. THREE MONTHS ENDED SEPTEMBER 30, NINE MONTHS ENDED SEPTEMBER 30, Dollars in thousands, except per share data 2022 2021 2022 2021 Weighted average common shares outstanding Weighted average common shares outstanding 330,788,997 145,594,127 211,740,767 143,305,737 Non-vested shares (1,983,742) (1,776,508) (1,933,957) (1,784,544) Weighted average common shares outstanding - basic 328,805,255 143,817,619 209,806,810 141,521,193 Weighted average common shares outstanding - basic 328,805,255 143,817,619 209,806,810 141,521,193 Dilutive effect of forward equity shares — — — 14,036 Dilutive effect of OP Units 3,167,668 — 1,067,493 — Dilutive effect of employee stock purchase plan 58,461 — 69,687 78,200 Weighted average common shares outstanding - diluted 332,031,384 143,817,619 210,943,990 141,613,429 Net Income (loss) attributable to common stockholders $ 28,304 $ (2,066) $ 76,661 $ 45,052 Dividends paid on nonvested share-based awards (610) (537) (1,817) (1,617) Net income (loss) applicable to common stockholders- basic $ 27,694 $ (2,603) $ 74,844 $ 43,435 Net income attributable to OP units 312 — 312 — Net income (loss) applicable to common stockholders - diluted $ 28,006 $ (2,603) $ 75,156 $ 43,435 Basic earnings per common share - net income $ 0.08 $ (0.02) $ 0.36 $ 0.31 Diluted earnings per common share - net income $ 0.08 $ (0.02) $ 0.35 $ 0.31
Summary of the activity under the incentive plan and restricted stock unit	A summary of the activity under the Company's share-based incentive plans for the three and nine months ended September 30, 2022 and 2021 is included in the table below. THREE MONTHS ENDED SEPTEMBER 30, NINE MONTHS ENDED SEPTEMBER 30, 2022 2021 2022 2021 Share-based awards, beginning of period 1,941,709 1,778,308 1,562,028 1,766,061 Granted 71,852 — 513,876 203,701 Vested (7,434) — (68,481) (191,454) Forfeited (4,130) (2,957) (5,426) (2,957) Share-based awards, end of period 2,001,997 1,775,351 2,001,997 1,775,351 The following is a summary of the RSU activity during the three and nine months ended September 30, 2022: THREE MONTHS ENDED SEPTEMBER 30, NINE MONTHS ENDED SEPTEMBER 30, Restricted Stock Units Weighted Average Grant Date Fair Value Restricted Stock Units Weighted Average Grant Date Fair Value Non-vested, beginning of period 294,932 — — — Granted — — 294,932 $ 33.04 Vested — — — — Non-vested as of September 30, 2022 294,932 294,932
Schedule of stock options, valuation assumptions	THREE MONTHS ENDED MARCH 31, Volatility 30.0 % Dividend assumption Accrued Expected term 3 years Risk-free rate 1.02 % Stock price (per share) $31.68
Summary of employee stock purchase plan activity	A summary of the activity under the ESPP for the three and nine months ended September 30, 2022 and 2021 is included in the table below. THREE MONTHS ENDED SEPTEMBER 30, NINE MONTHS ENDED SEPTEMBER 30, 2022 2021 2022 2021 Outstanding and exercisable, beginning of period 405,534 389,414 348,514 341,647 Granted — — 255,960 253,200 Exercised (4,576) (5,323) (17,094) (24,300) Forfeited (37,628) (18,961) (83,417) (60,995) Expired — — (140,633) (144,422) Outstanding and exercisable, end of period 363,330 365,130 363,330 365,130

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value And Carrying Values For Notes And Bonds Payable, Real Estate Notes Receivable, And Notes Receivable	The table below details the fair values and carrying values for notes and bonds payable and real estate notes receivable at September 30, 2022 and December 31, 2021. September 30, 2022 December 31, 2021 Dollars in millions CARRYING VALUE FAIR VALUE CARRYING VALUE FAIR VALUE Notes and bonds payable 1 $ 5,570.1 $ 5,321.0 $ 1,801.3 $ 1,797.4 Real estate notes receivable 1 $ 79.0 $ 79.0 $ — $ — 1 Level 2 – model-derived valuations in which significant inputs and significant value drivers are observable in active markets.

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) $ in Thousands, shares in Millions, ft² in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2022 USD ($) ft² variable_interest_entity property building state financing_receivable shares	Sep. 30, 2022 USD ($) ft² variable_interest_entity property building state financing_receivable shares	Dec. 31, 2021 USD ($) building
Business Overview:
Gross investment amount, total	$ 14,200,000	$ 14,200,000
Number of real estate properties | property	695	695
Number of states that the company owns real estate in, whole units | state	35	35
Approximate square feet invested in by company | ft²	40.7	40.7
Approximate square feet for which Nationwide property management services provided by company | ft²	38.9	38.9
Number of buildings owned by joint venture with TIAA | building	33	33
Number of variable interest entities | variable_interest_entity	3	3
Number of consolidated variable interest entities | variable_interest_entity	2	2
Number of unconsolidated variable interest entities | property	1	1
Limited partner's capital, units issued (in shares) | shares	4	4
Limited partner's capital, units outstanding (in shares) | shares	4	4
OP Units, issued and outstanding, held by non-controlling interest holders (percent)	1.10%	1.10%
Equity ownership for consolidation (percent)	100%	100%
Leases [Abstract]
Real estate notes receivable, net	$ 79,036	$ 79,036	$ 0
Number of recognized lease financial receivables | financing_receivable	2	2
Sales-type Lease, Interest Income, Lease Receivable	$ 2,000	$ 5,900
Real Estate Properties Held in Joint Ventures
Business Overview:
Joint venture ownership (percent)	49%	49%
Notes Receivable
Leases [Abstract]
Interest income	$ 1,300	$ 1,300
Nashville, Tennessee | Medical office building
Leases [Abstract]
Number of buildings acquired in sale leaseback transactions | building			2
Buildings acquired in sale leaseback transactions	$ 73,900	$ 73,900

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Type of Revenue	$ 4,057	$ 2,969	$ 9,270	$ 7,347
Parking income
Disaggregation of Revenue [Line Items]
Type of Revenue	2,428	2,187	6,100	5,725
Management fee income
Disaggregation of Revenue [Line Items]
Type of Revenue	1,426	723	2,864	1,381
Miscellaneous
Disaggregation of Revenue [Line Items]
Type of Revenue	$ 203	$ 59	$ 306	$ 241

Merger with HTA - Narrative (De

Merger with HTA - Narrative (Details) - USD ($)		2 Months Ended	3 Months Ended		9 Months Ended
	Jul. 20, 2022	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Business Acquisition [Line Items]
Common stock, par value (dollars per share)		$ 0.01	$ 0.01		$ 0.01		$ 0.01
Goodwill	$ 145,404,000	$ 148,891,000	$ 148,891,000		$ 148,891,000		$ 3,487,000
Goodwill expected to be tax deductible	$ 0
Merger-related costs			$ 79,402,000	$ 0	92,603,000	$ 0
Revenues contributed from Legacy HTA		157,400,000			157,400,000
Results of operations from Legacy HTA		$ 20,600,000			$ 20,600,000
HealthCare Realty Trust Incorporated | Common Class A
Business Acquisition [Line Items]
Common stock, par value (dollars per share)	$ 0.01
HealthCare Realty Trust, Inc.
Business Acquisition [Line Items]
Common stock, par value (dollars per share)	0.01
Healthcare Trust Of America, Inc
Business Acquisition [Line Items]
Common stock, par value (dollars per share)	$ 0.01
Conversion Ratio	1
Dividends declared per common share, during the period (in dollars per share)	$ 4.82

Merger with HTA (Details)

Merger with HTA (Details)		9 Months Ended
	Jul. 20, 2022 USD ($) $ / shares shares	Sep. 30, 2022 USD ($) shares	Dec. 31, 2021 shares
Business Acquisition [Line Items]
Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)	228,857,717	380,572,000	150,457,000
Implied shares of Legacy HR Common Stock issued (in shares)	228,520,990
Adjusted closing price of Legacy HR Common Stock on July 20, 2022 (in dollars per share) | $ / shares	$ 24.37
Value of implied Legacy HR Common Stock issued | $	$ 5,569,057,000
Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services | $		$ 7,406,000
Consideration transferred | $		$ 5,576,463,000
Healthcare Trust Of America, Inc
Business Acquisition [Line Items]
Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)	228,520,990
Exchange ratio	1
Common Stock, fractional (in shares)	192
Healthcare Trust Of America, Inc | Restricted stock
Business Acquisition [Line Items]
Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)	336,535
Common Stock, withheld (in shares)	215,764

Merger with HTA - Schedule of F

Merger with HTA - Schedule of Fair Values of the Assets Acquired And Liabilities Assumed (Details) - USD ($) $ in Thousands	Jul. 20, 2022	Sep. 30, 2022	Dec. 31, 2021
Real estate investments
Land	$ 985,926
Buildings and improvements	6,960,418
Lease intangible assets	831,920
Financing lease right-of-use assets	9,874
Construction in progress	10,071
Land held for development	46,538
Total real estate investments	8,844,747
Assets held for sale, net	707,442
Investments in unconsolidated joint ventures	67,892
Cash and cash equivalents	26,034
Restricted cash	1,123,647
Operating lease right-of-use assets	198,261
Other assets, net	209,163
Total assets acquired	11,177,186
LIABILITIES
Notes and bonds payable	3,991,300
Accounts payable and accrued liabilities	1,227,570
Liabilities of assets held for sale	28,677
Operating lease liabilities	173,948
Financing lease liabilities	10,720
Other liabilities	203,210
Total liabilities assumed	5,635,425
Net identifiable assets acquired	5,541,761
Non-controlling interest	110,702
Goodwill	$ 145,404	$ 148,891	$ 3,487
Weighted average amortization period for the acquired lease intangible assets	5 years 6 months
Gross contractual accounts receivable	$ 34,600
Gross contractual accounts receivable, not expected to be collectible	12,300
Gross contractual real estate notes receivable	78,700
Gross contractual real estate notes receivable at fair value	$ 74,800

Merger with HTA - Schedule of B

Merger with HTA - Schedule of Business Acquisition, Pro Forma Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Business Combination and Asset Acquisition [Abstract]
Total revenues	$ 352,744	$ 332,465	$ 1,054,809	$ 982,192
Net income	$ 115,496	$ (14,930)	$ 160,120	$ (79,754)

Real Estate Investments - Acqui

Real Estate Investments - Acquisitions (Details) $ in Thousands																				3 Months Ended			9 Months Ended
	Oct. 12, 2022 USD ($) ft²	Oct. 04, 2022 property	Sep. 29, 2022 USD ($) ft²	Sep. 15, 2022 USD ($) ft²	Aug. 30, 2022 property	Aug. 18, 2022 USD ($) ft²	Aug. 11, 2022 USD ($) ft²	Aug. 10, 2022 USD ($) ft²	Aug. 09, 2022 USD ($) ft²	Aug. 05, 2022 property	Aug. 01, 2022 USD ($) ft²	Jun. 09, 2022 USD ($) ft² property	May 31, 2022 USD ($) ft² property	Apr. 29, 2022 USD ($) ft² property	Apr. 28, 2022 USD ($) ft²	Apr. 13, 2022 USD ($) ft² property	Apr. 07, 2022 USD ($) ft²	Mar. 07, 2022 USD ($) ft² property	Feb. 11, 2022 USD ($) ft²	Sep. 30, 2022 USD ($) ft²	Jun. 30, 2022 USD ($) ft²	Mar. 31, 2022 USD ($) ft²	Sep. 30, 2022 USD ($) ft²
Business Acquisition [Line Items]
Purchase price																							$ 5,576,463
Total real estate acquisitions
Business Acquisition [Line Items]
Purchase price																				$ 91,253	$ 163,762	$ 122,175
Cash assumed in Merger, including restricted cash for special dividend payment																				89,502	162,457	121,171
Real estate																				90,044	153,407	116,889	90,044
Other																				$ (542)	$ 9,050	$ 4,282	$ (542)
Square footage | ft²																				242,602	359,706	184,396	242,602
Real Estate Acquisitions - Year to Date
Business Acquisition [Line Items]
Purchase price																							$ 377,190
Cash assumed in Merger, including restricted cash for special dividend payment																							373,130
Real estate																				$ 360,340			360,340
Other																				$ 12,790			$ 12,790
Square footage | ft²																				786,704			786,704
Dallas, TX
Business Acquisition [Line Items]
Purchase price																			$ 8,175
Cash assumed in Merger, including restricted cash for special dividend payment																			8,185
Real estate																			8,202
Other																			$ (17)
Square footage | ft²																			18,000
Number of properties acquired | property					6
Dallas, TX | Subsequent event
Business Acquisition [Line Items]
Number of properties acquired | property		2
San Francisco, CA
Business Acquisition [Line Items]
Purchase price																		$ 114,000
Cash assumed in Merger, including restricted cash for special dividend payment																		112,986
Real estate																		108,687
Other																		$ 4,299
Square footage | ft²																		166,396
Number of properties acquired | property																		3
Atlanta, GA
Business Acquisition [Line Items]
Purchase price								$ 11,800									$ 6,912
Cash assumed in Merger, including restricted cash for special dividend payment								11,525									7,054
Real estate								12,038									7,178
Other								$ (513)									$ (124)
Square footage | ft²								43,496									21,535
Denver, CO
Business Acquisition [Line Items]
Purchase price							$ 14,800									$ 6,320
Cash assumed in Merger, including restricted cash for special dividend payment							13,902									5,254
Real estate							13,918									5,269
Other							$ (16)									$ (15)
Square footage | ft²							34,785									12,207
Colorado Springs, CO
Business Acquisition [Line Items]
Purchase price																$ 13,680
Cash assumed in Merger, including restricted cash for special dividend payment																13,686
Real estate																13,701
Other																$ (15)
Square footage | ft²																25,800
Number of properties acquired | property																2
Seattle, WA
Business Acquisition [Line Items]
Purchase price											$ 4,850				$ 8,350
Cash assumed in Merger, including restricted cash for special dividend payment											4,806				8,334
Real estate											4,882				8,370
Other											$ (76)				$ (36)
Square footage | ft²											10,593				13,256
Houston, TX
Business Acquisition [Line Items]
Purchase price															$ 36,250
Cash assumed in Merger, including restricted cash for special dividend payment															36,299
Real estate															36,816
Other															$ (517)
Square footage | ft²															76,781
Los Angeles, CA
Business Acquisition [Line Items]
Purchase price														$ 35,000
Cash assumed in Merger, including restricted cash for special dividend payment														35,242
Real estate														25,400
Other														$ 9,842
Square footage | ft²														34,282
Number of properties acquired | property										4				2
Oklahoma City, OK
Business Acquisition [Line Items]
Purchase price														$ 11,100
Cash assumed in Merger, including restricted cash for special dividend payment														11,259
Real estate														11,334
Other														$ (75)
Square footage | ft²														34,944
Raleigh, NC
Business Acquisition [Line Items]
Purchase price						$ 11,375			$ 3,783				$ 27,500
Cash assumed in Merger, including restricted cash for special dividend payment						10,670			3,878				26,710
Real estate						10,547			3,932				27,127
Other						$ 123			$ (54)				$ (417)
Square footage | ft²						31,318			11,345				85,113
Number of properties acquired | property													3
Tampa, FL
Business Acquisition [Line Items]
Purchase price												$ 18,650
Cash assumed in Merger, including restricted cash for special dividend payment												18,619
Real estate												18,212
Other												$ 407
Square footage | ft²												55,788
Number of properties acquired | property												2
Jacksonville, FL
Business Acquisition [Line Items]
Purchase price									$ 18,195
Cash assumed in Merger, including restricted cash for special dividend payment									18,508
Real estate									18,583
Other									$ (75)
Square footage | ft²									34,133
Jacksonville, FL | Subsequent event
Business Acquisition [Line Items]
Purchase price	$ 3,600
Square footage | ft²	6,200
Nashville, TN
Business Acquisition [Line Items]
Purchase price				$ 21,000
Cash assumed in Merger, including restricted cash for special dividend payment				20,764
Real estate				20,572
Other				$ 192
Square footage | ft²				61,932
Austin, TX
Business Acquisition [Line Items]
Purchase price			$ 5,450
Cash assumed in Merger, including restricted cash for special dividend payment			5,449
Real estate			5,572
Other			$ (123)
Square footage | ft²			15,000

Real Estate Investments - Uncon

Real Estate Investments - Unconsolidated Joint Venture Acquisitions (Details) $ in Thousands				3 Months Ended		9 Months Ended
	Aug. 05, 2022 property	Apr. 29, 2022 property	Mar. 07, 2022 USD ($) ft² property	Sep. 30, 2022 USD ($) ft²	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) ft² property	Sep. 30, 2021 USD ($)
Equity Method Investments [Roll Forward]
Investments in unconsolidated joint ventures, beginning of period						$ 161,942
Equity loss recognized during the period				$ (124)	$ (183)	(776)	$ (404)
Net LLC investments at the end of the period				327,752		327,752
San Francisco, CA
Real Estate [Line Items]
Number of properties acquired | property			3
Los Angeles, CA
Real Estate [Line Items]
Number of properties acquired | property	4	2
Joint venture, ownership (in percentage)	20%
Medical office building | Joint Venture Acquisitions
Real Estate [Line Items]
PURCHASE PRICE				100,975		100,975
Cash Consideration						99,173
REAL ESTATE				97,569		97,569
Other				$ 1,604		$ 1,604
SQUARE FOOTAGE | ft²				214,124		214,124
Medical office building | San Francisco, CA
Real Estate [Line Items]
Number of properties acquired | property			3
Medical office building | San Francisco, CA | Joint Venture Acquisitions
Real Estate [Line Items]
PURCHASE PRICE			$ 67,175
Cash Consideration			66,789
REAL ESTATE			65,179
Other			$ 1,610
SQUARE FOOTAGE | ft²			110,865
Joint venture ownership (percent)			50%
Medical office building | Los Angeles, CA
Real Estate [Line Items]
Number of properties acquired | property			2
Medical office building | Los Angeles, CA | Joint Venture Acquisitions
Real Estate [Line Items]
PURCHASE PRICE			$ 33,800
Cash Consideration			32,384
REAL ESTATE			32,390
Other			$ (6)
SQUARE FOOTAGE | ft²			103,259
Joint venture ownership (percent)			50%
Parking Garages
Equity Method Investments [Roll Forward]
Investments in unconsolidated joint ventures, beginning of period				$ 210,781	117,935	$ 161,942	73,137
New investments during the period				117,880	4,593	167,479	49,612
Equity loss recognized during the period				(124)	(183)	(776)	(404)
Owner distributions				(785)	0	(893)	0
Net LLC investments at the end of the period				$ 327,752	$ 122,345	$ 327,752	$ 122,345
Parking Garages | Los Angeles, CA
Real Estate [Line Items]
Number of joint ventures | property						2
Parking Garages | Los Angeles, CA | Limited Liability Company One
Real Estate [Line Items]
Joint venture, ownership (in percentage)						20%
Parking Garages | Los Angeles, CA | Limited Liability Company Two
Real Estate [Line Items]
Joint venture, ownership (in percentage)						40%

Real Estate Investments - Dispo

Real Estate Investments - Dispositions (Details) $ in Thousands										9 Months Ended
	Oct. 04, 2022 USD ($) ft² property	Aug. 31, 2022 USD ($) ft² property	Aug. 30, 2022 USD ($) ft² property	Aug. 05, 2022 USD ($) ft² property	Aug. 04, 2022 USD ($) ft² property	Jul. 29, 2022 USD ($) ft² property	Apr. 29, 2022 property	Apr. 15, 2022 USD ($) ft² property	Feb. 24, 2022 USD ($) ft² property	Sep. 30, 2022 USD ($) ft²	Nov. 09, 2022 USD ($) ft²	Oct. 21, 2022 USD ($) ft²
Real Estate Dispositions
Real Estate Dispositions [Line Items]
SALE PRICE										$ 892,447
CLOSING ADJUSTMENTS										(25,949)
NET PROCEEDS										866,498
NET REAL ESTATE INVESTMENT										660,993
Other (including receivables)										8,228
GAIN/(IMPAIRMENT)										$ 197,277
SQUARE FOOTAGE | ft²										1,991,669
Real Estate Dispositions | Subsequent event
Real Estate Dispositions [Line Items]
SALE PRICE											$ 136,025
SQUARE FOOTAGE | ft²											426,238
Loveland, CO
Real Estate Dispositions [Line Items]
SALE PRICE									$ 84,950
CLOSING ADJUSTMENTS									(45)
NET PROCEEDS									84,905
NET REAL ESTATE INVESTMENT									40,095
Other (including receivables)									4
GAIN/(IMPAIRMENT)									$ 44,806
SQUARE FOOTAGE | ft²									150,291
Number of properties acquired | property									2
San Antonio, TX
Real Estate Dispositions [Line Items]
SALE PRICE								$ 25,500
CLOSING ADJUSTMENTS								(2,272)
NET PROCEEDS								23,228
NET REAL ESTATE INVESTMENT								14,381
Other (including receivables)								284
GAIN/(IMPAIRMENT)								$ 8,563
SQUARE FOOTAGE | ft²								201,523
Number of properties acquired | property								2
GA, FL, PA
Real Estate Dispositions [Line Items]
SALE PRICE						$ 133,100
CLOSING ADJUSTMENTS						(8,109)
NET PROCEEDS						124,991
NET REAL ESTATE INVESTMENT						124,991
Other (including receivables)						0
GAIN/(IMPAIRMENT)						$ 0
SQUARE FOOTAGE | ft²						316,739
Number of properties acquired | property						4
GA, FL, TX
Real Estate Dispositions [Line Items]
SALE PRICE					$ 160,917
CLOSING ADJUSTMENTS					(5,893)
NET PROCEEDS					155,024
NET REAL ESTATE INVESTMENT					151,819
Other (including receivables)					3,205
GAIN/(IMPAIRMENT)					$ 0
SQUARE FOOTAGE | ft²					343,545
Number of properties acquired | property					6
Los Angeles, CA
Real Estate Dispositions [Line Items]
SALE PRICE				$ 134,845
CLOSING ADJUSTMENTS				(3,102)
NET PROCEEDS				131,743
NET REAL ESTATE INVESTMENT				131,332
Other (including receivables)				411
GAIN/(IMPAIRMENT)				$ 0
SQUARE FOOTAGE | ft²				283,780
Number of properties acquired | property				4			2
Values and square feet, represented percentage (in percent)				100%
Joint venture, ownership (in percentage)				20%
Dallas, TX
Real Estate Dispositions [Line Items]
SALE PRICE			$ 114,290
CLOSING ADJUSTMENTS			(682)
NET PROCEEDS			113,608
NET REAL ESTATE INVESTMENT			113,608
Other (including receivables)			0
GAIN/(IMPAIRMENT)			$ 0
SQUARE FOOTAGE | ft²			189,385
Number of properties acquired | property			6
Values and square feet, represented percentage (in percent)				100%
Joint venture, ownership (in percentage)				40%
Dallas, TX | Subsequent event
Real Estate Dispositions [Line Items]
SALE PRICE	$ 104,025
SQUARE FOOTAGE | ft²	291,328
Number of properties acquired | property	2
Indianapolis, IN
Real Estate Dispositions [Line Items]
SALE PRICE		$ 238,845
CLOSING ADJUSTMENTS		(5,846)
NET PROCEEDS		232,999
NET REAL ESTATE INVESTMENT		84,767
Other (including receivables)		4,324
GAIN/(IMPAIRMENT)		$ 143,908
SQUARE FOOTAGE | ft²		506,406
Number of properties acquired | property		5
Number of properties acquired in the merger | property		2
Houston, TX | Subsequent event
Real Estate Dispositions [Line Items]
SALE PRICE												$ 32,000
SQUARE FOOTAGE | ft²												134,910

Real Estate Investments - Asset

Real Estate Investments - Assets Held for Sale (Details) $ in Thousands	Sep. 30, 2022 USD ($) property	Dec. 31, 2021 USD ($) property
Long Lived Assets Held-for-sale [Line Items]
Land	$ 1,449,550	$ 387,918
Building and improvements	11,439,797	4,337,641
Personal property	11,680	11,761
Real Estate Investment Property, at Cost	14,185,279	5,104,942
Accumulated depreciation	(1,468,736)	(1,338,743)
Real estate assets held for sale, net	12,716,543	3,766,199
Operating lease right-of-use assets	321,365	128,386
Assets held for sale, net	185,074	57
Operating lease liabilities	268,840	96,138
Financing lease liabilities	72,378	22,551
Liabilities of assets held for sale	$ 10,644	$ 294
Disposal Group, Held-for-sale, Not Discontinued Operations
Long Lived Assets Held-for-sale [Line Items]
Number of properties held for sale | property	6	0
Land	$ 10,594	$ 0
Building and improvements	199,821	0
Lease intangibles	11,389	0
Personal property	211	0
Financing lease right-of-use assets	307	0
Real Estate Investment Property, at Cost	222,322	0
Accumulated depreciation	(47,051)	0
Real estate assets held for sale, net	175,271	0
Operating lease right-of-use assets	1,193	0
Other assets, net	8,610	57
Assets held for sale, net	185,074	57
Accounts payable and accrued liabilities	3,768	169
Operating lease liabilities	864	0
Financing lease liabilities	2,427	0
Other liabilities	3,585	125
Liabilities of assets held for sale	$ 10,644	$ 294

Leases - Lease Income (Details)

Leases - Lease Income (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Mar. 30, 2022 USD ($) a
Lessee, Lease, Description [Line Items]
Rental income	$ 298,931	$ 131,746	$ 578,052	$ 388,620
Land held for development to other assets					$ 1,800
Texas | Land Held For Devlopment
Lessee, Lease, Description [Line Items]
Joint venture, adjacent land parcel (acres) | a					1.9

Leases - Lessor Accounting (Det

Leases - Lessor Accounting (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Future Operating Lease Payments Receivable [Abstract]
2022	$ 243,946
2023	937,733
2024	816,000
2025	702,251
2026	605,417
2027 and thereafter	2,242,792
Total	$ 5,548,139

Leases - Ground Leases (Details

Leases - Ground Leases (Details) ft² in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022 USD ($) property	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) ft² property	Sep. 30, 2021 USD ($)
Lessee, Lease, Description [Line Items]
Number of properties subject to ground leases	243		243
Square feet subject to ground leases | ft²			17.8
Number of prepaid ground leases			75
Amortization of prepaid rent | $	$ 0.5	$ 0.1	$ 0.8	$ 0.4
Number of non-prepaid ground leases	168		168
Minimum
Lessee, Lease, Description [Line Items]
Ground lease, initial term	40 years		40 years
Maximum
Lessee, Lease, Description [Line Items]
Ground lease, initial term	99 years		99 years

Leases - Future Minimum Lease P

Leases - Future Minimum Lease Payments (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
OPERATING
2022	$ 3,665
2023	15,606
2024	15,193
2025	14,715
2026	14,735
2027 and thereafter	894,018
Total undiscounted lease payments	957,932
Discount	(689,092)
Lease liabilities	268,840	$ 96,138
FINANCING
2022	503
2023	2,139
2024	2,182
2025	2,218
2026	2,255
2027 and thereafter	398,092
Total undiscounted lease payments	407,389
Discount	(335,011)
Lease liabilities	$ 72,378	$ 22,551

Leases - Lease Cost (Details)

Leases - Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating lease cost
Operating lease expense	$ 4,204	$ 1,196	$ 6,613	$ 3,555
Variable lease expense	1,061	1,016	3,123	2,883
Finance lease cost
Amortization of right-of-use assets	381	90	884	267
Interest on lease liabilities	861	255	1,913	748
Total lease expense	6,507	2,557	12,533	7,453
Other information
Operating cash flows outflows related to operating leases	3,847	1,424	8,443	5,855
Operating cash flows outflows related to financing leases	476	151	1,262	678
Financing cash flows outflows related to financing leases	3	6	3	162
Right-of-use assets obtained in exchange for new finance lease liabilities	198,261	1,420		1,420
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 9,874	$ 8,298	$ 50,463	$ 8,298
Weighted-average years remaining lease term (excluding renewal options) - operating leases	50 years 2 months 12 days	47 years 9 months 18 days	50 years 2 months 12 days	47 years 9 months 18 days
Weighted-average years remaining lease term (excluding renewal options) - finance leases	60 years 1 month 6 days	63 years 2 months 12 days	60 years 1 month 6 days	63 years 2 months 12 days
Weighted-average discount rate - operating leases	5.70%	5.60%	5.70%	5.60%
Weighted-average discount rate - finance leases	5%	5.40%	5%	5.40%

Other Assets and Liabilities -

Other Assets and Liabilities - Other Assets (Details) - USD ($) $ in Thousands	1 Months Ended
	Oct. 31, 2022	Sep. 30, 2022	Dec. 31, 2021
Other Assets and Liabilities [Line Items]
Above-market intangible assets, net		$ 86,410	$ 4,966
Prepaid assets		85,053	58,618
Real estate notes receivable, net		79,036	0
Straight-line rent receivables		78,038	70,784
Accounts receivable, net		36,103	14,072
Additional long-lived assets, net		21,722	20,048
Interest rate swap assets		16,136	0
Ground lease modification, net		8,170	8,511
Other receivables, net		7,258	0
Debt issuance costs, net		6,504	1,813
Project costs		4,001	5,129
Net investment in lease		1,828	0
Customer relationship intangible assets, net		1,134	1,174
Other		6,842	558
Other Assets		$ 438,235	$ 185,673
Subsequent event
Other Assets and Liabilities [Line Items]
Real estate transaction	$ 15,000

Other Assets and Liabilities _2

Other Assets and Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued property taxes	$ 86,192	$ 35,295
Accounts payable and capital expenditures	61,461	17,036
Accrued interest	24,959	12,060
Accrued income and franchise taxes	2,685	983
Retainage accrued on construction invoices	1,304	2,215
Other operating accruals	54,417	18,519
Accounts payable and accrued liabilities	$ 231,018	$ 86,108

Other Assets and Liabilities _3

Other Assets and Liabilities - Other Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Below-market intangible liabilities, net	$ 113,118	$ 4,931
Deferred revenue	60,675	45,130
Security deposits	28,299	11,116
Interest rate swap liability	0	5,917
Other	1,306	293
Other liabilities	$ 203,398	$ 67,387

Notes and Bonds Payable (Detail

Notes and Bonds Payable (Details) - USD ($)	9 Months Ended
	Sep. 30, 2022	Jul. 20, 2022	Feb. 24, 2022	Feb. 18, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Notes and bonds payable	$ 5,570,139,000				$ 1,801,325,000
Mortgages
Debt Instrument [Line Items]
Effective interest rate			6.17%	4.70%
Line of credit | $1.5 billion Unsecured Credit Facility
Debt Instrument [Line Items]
Notes and bonds payable	$ 190,600,000				0
Effective interest rate	3.99%
Credit facility	$ 1,500,000,000
Line of credit | $700 million Unsecured Credit Facility
Debt Instrument [Line Items]
Notes and bonds payable	$ 0				210,000,000
Effective interest rate	0%
Credit facility	$ 700,000,000	$ 700,000,000
Line of credit | Revolving Credit Facility | $1.5 billion Unsecured Credit Facility
Debt Instrument [Line Items]
Credit facility		$ 1,500,000,000
Medium-term notes | $1.125 billion Asset Sale Term Loan
Debt Instrument [Line Items]
Notes and bonds payable	$ 421,919,000				0
Effective interest rate	4.07%
FACE VALUE	$ 1,125,000,000
Medium-term notes | $350 million Unsecured Term Loan due 2023, net of issuance costs
Debt Instrument [Line Items]
Notes and bonds payable	$ 348,735,000				0
Effective interest rate	4.10%
FACE VALUE	$ 350,000,000
Medium-term notes | $200 million Unsecured Term Loan due 2024, net of issuance costs
Debt Instrument [Line Items]
Notes and bonds payable	$ 199,611,000				199,460,000
Effective interest rate	3.51%
FACE VALUE	$ 200,000,000
Medium-term notes | $300 million Unsecured Term Loan due 2025, net of issuance costs
Debt Instrument [Line Items]
Notes and bonds payable	$ 299,930,000				0
Effective interest rate	2.47%
FACE VALUE	$ 300,000,000
Medium-term notes | $150 million Unsecured Term Loan due 2026, net of issuance costs
Debt Instrument [Line Items]
Notes and bonds payable	$ 149,458,000				149,376,000
Effective interest rate	3.32%
FACE VALUE	$ 150,000,000
Medium-term notes | $200 million Unsecured Term Loan due 2027, net of issuance costs
Debt Instrument [Line Items]
Notes and bonds payable	$ 199,328,000				0
Effective interest rate	2.27%
FACE VALUE	$ 200,000,000
Medium-term notes | $300 million Unsecured Term Loan due 2028, net of issuance costs
Debt Instrument [Line Items]
Notes and bonds payable	$ 297,764,000				0
Effective interest rate	3.56%
FACE VALUE	$ 300,000,000
Senior notes | Senior Notes due 2025, net of discount and issuance costs
Debt Instrument [Line Items]
Notes and bonds payable	$ 249,025,000				249,040,000
Effective interest rate	4.12%
Senior notes | Senior Notes due 2026, net of discount and issuance costs
Debt Instrument [Line Items]
Notes and bonds payable	$ 569,786,000				0
Effective interest rate	4.94%
Senior notes | Senior Notes due 2027, net of discount and issuance costs
Debt Instrument [Line Items]
Notes and bonds payable	$ 478,541,000				0
Effective interest rate	4.76%
Senior notes | Senior Notes due 2028
Debt Instrument [Line Items]
Notes and bonds payable	$ 296,711,000				296,612,000
Effective interest rate	3.85%
Senior notes | Senior notes due 2030, net of discount and issuance costs
Debt Instrument [Line Items]
Notes and bonds payable	$ 562,974,000				0
Effective interest rate	5.30%
Senior notes | Senior notes due 2030, net of discount and issuance costs
Debt Instrument [Line Items]
Notes and bonds payable	$ 296,787,000				296,813,000
Effective interest rate	2.72%
Senior notes | Senior Notes due 2031, net of discount and issuance costs
Debt Instrument [Line Items]
Notes and bonds payable	$ 628,617,000				0
Effective interest rate	5.13%
Senior notes | Senior Notes due 2031
Debt Instrument [Line Items]
Notes and bonds payable	$ 295,424,000				295,374,000
Effective interest rate	2.25%
Mortgages | Mortgage notes payable
Debt Instrument [Line Items]
Notes and bonds payable	$ 84,929,000				$ 104,650,000
Effective interest rate	3.97%
Settled interest rate swaps | Medium-term notes | $200 million Unsecured Term Loan due 2024, net of issuance costs
Debt Instrument [Line Items]
AMOUNT	$ 675,000,000
Weighted average interest rate (percent)	1.57%
Basis spread on variable rate	105%

Notes and Bonds Payable - Narra

Notes and Bonds Payable - Narrative (Details)	Jul. 20, 2022 USD ($) extension_option	Feb. 24, 2022 USD ($) ft²	Feb. 18, 2022 USD ($) ft²	Sep. 30, 2022 USD ($)	Jul. 22, 2022
Amended and Restated Credit Agreement | Revolving Credit Facility
Debt Instrument [Line Items]
Outstanding principal repaid	$ 700,000,000
Term Loan Facility Due May 2026
Debt Instrument [Line Items]
Outstanding principal repaid	200,000,000
Term Loan Facility Due June 2026
Debt Instrument [Line Items]
Outstanding principal repaid	150,000,000
Amended Term Loan Facility Due May 2026
Debt Instrument [Line Items]
FACE VALUE	$ 200,000,000
Number of extension options | extension_option	2
Extension option period	1 year
Amended Term Loan Facility Due June 2026
Debt Instrument [Line Items]
FACE VALUE	$ 150,000,000
Credit Facility Maturing October 2025 | Revolving Credit Facility
Debt Instrument [Line Items]
Number of extension options | extension_option	2
Credit facility	$ 1,500,000,000			$ 1,000,000,000
Term Loan Facility Due October 2025
Debt Instrument [Line Items]
Credit facility	300,000,000
Term Loan Facility Due January 2024 - July 20, 2027
Debt Instrument [Line Items]
Credit facility	$ 200,000,000
Delayed Term Loan Facility due July 20, 2023
Debt Instrument [Line Items]
Number of extension options | extension_option	2
Credit facility	$ 350,000,000
Delayed credit facility, period available for draws	12 months
Term Loan Facility Due January 20, 2028
Debt Instrument [Line Items]
Credit facility	$ 300,000,000
Healthcare Trust Of America, Inc
Debt Instrument [Line Items]
FACE VALUE				2,550,000,000
Healthcare Trust Of America, Inc | Senior Notes due 2025
Debt Instrument [Line Items]
Business combination, validly tendered and accepted notes, exchange amount				$ 250,000,000
Fixed interest rate (percent)				3.875%	3.875%
Healthcare Trust Of America, Inc | Senior Notes due 2028
Debt Instrument [Line Items]
Business combination, validly tendered and accepted notes, exchange amount				$ 300,000,000
Fixed interest rate (percent)				3.625%	3.625%
Healthcare Trust Of America, Inc | Senior Notes due 2030
Debt Instrument [Line Items]
Business combination, validly tendered and accepted notes, exchange amount				$ 300,000,000
Fixed interest rate (percent)				2.40%	2.40%
Healthcare Trust Of America, Inc | Senior Notes due 2031
Debt Instrument [Line Items]
Business combination, validly tendered and accepted notes, exchange amount				$ 300,000,000
Fixed interest rate (percent)				2.05%	2.05%
Mortgages
Debt Disclosure [Abstract]
Effective interest rate		6.17%	4.70%
Debt Instrument [Line Items]
Effective interest rate		6.17%	4.70%
Redemption price		$ 6,400,000	$ 12,600,000
Outstanding principal repaid		5,800,000	11,000,000
Make whole amount			1,600,000
Unamortized premium		600,000	800,000
Write off upon payoff		$ 100,000	$ 100,000
Mortgages | Los Angeles, CA
Debt Instrument [Line Items]
Encumbered square footage | ft²			56,762
Mortgages | Colorado Springs, CO
Debt Instrument [Line Items]
Encumbered square footage | ft²		80,153

Notes and Bonds Payable - Sched

Notes and Bonds Payable - Schedule of Debt Exchange Offers (Details) - Healthcare Trust Of America, Inc - USD ($)	Sep. 30, 2022	Jul. 22, 2022
Senior Notes due 2025
Debt Instrument [Line Items]
Tenders and Consents Received as of the Expiration Date		$ 235,016,000
Percentage of Total Outstanding Principal Amount of Such Series of Old HR Notes		94.01%
Fixed interest rate (percent)	3.875%	3.875%
Senior Notes due 2028
Debt Instrument [Line Items]
Tenders and Consents Received as of the Expiration Date		$ 290,246,000
Percentage of Total Outstanding Principal Amount of Such Series of Old HR Notes		96.75%
Fixed interest rate (percent)	3.625%	3.625%
Senior Notes due 2030
Debt Instrument [Line Items]
Tenders and Consents Received as of the Expiration Date		$ 297,507,000
Percentage of Total Outstanding Principal Amount of Such Series of Old HR Notes		99.17%
Fixed interest rate (percent)	2.40%	2.40%
Senior Notes due 2031
Debt Instrument [Line Items]
Tenders and Consents Received as of the Expiration Date		$ 298,858,000
Percentage of Total Outstanding Principal Amount of Such Series of Old HR Notes		99.62%
Fixed interest rate (percent)	2.05%	2.05%

Notes and Bonds Payable - Sch_2

Notes and Bonds Payable - Schedule of Senior Notes Assumed with the Merger (Details) - Healthcare Trust Of America, Inc - USD ($)	9 Months Ended
	Sep. 30, 2022	Jul. 22, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
FACE VALUE	$ 2,550,000,000
Debt instrument, debt default, amount	$ 2,550,000,000		$ 0
Senior Notes due 2026
Debt Instrument [Line Items]
Debt instrument coupon interest rate (in percentage0	350%
FACE VALUE		$ 600,000,000
Debt instrument, debt default, amount	$ 600,000,000		0
Senior Notes due 2027
Debt Instrument [Line Items]
Debt instrument coupon interest rate (in percentage0	375%
FACE VALUE		500,000,000
Debt instrument, debt default, amount	$ 500,000,000		0
Senior Notes due 2030
Debt Instrument [Line Items]
Debt instrument coupon interest rate (in percentage0	310%
FACE VALUE		650,000,000
Debt instrument, debt default, amount	$ 650,000,000		0
Senior Notes due 2031
Debt Instrument [Line Items]
Debt instrument coupon interest rate (in percentage0	200%
FACE VALUE		$ 800,000,000
Debt instrument, debt default, amount	$ 800,000,000		$ 0

Derivative Financial Instrume_3

Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details) $ in Thousands	Nov. 09, 2022 USD ($) swap_agreement	Sep. 30, 2022 USD ($) swap_agreement
Interest Rate Swaps | Cash flow hedging | Designated as hedging instrument
Derivative [Line Items]
Number of instruments | swap_agreement		15
AMOUNT		$ 675,000
Weighted average interest rate (percent)		1.57%
Interest Rate Swaps | Cash flow hedging | Designated as hedging instrument | Subsequent event
Derivative [Line Items]
Number of instruments | swap_agreement	2
Interest Rate Swap, Expiring December 16, 2022 | Cash flow hedging | Designated as hedging instrument
Derivative [Line Items]
AMOUNT		$ 75,000
Weighted average interest rate (percent)		2.37%
Interest Rate Swap, Expiring January 31, 2023 | Cash flow hedging | Designated as hedging instrument
Derivative [Line Items]
AMOUNT		$ 300,000
Weighted average interest rate (percent)		1.42%
Interest Rate Swap, Expiring January 15, 2024 | Cash flow hedging | Designated as hedging instrument
Derivative [Line Items]
AMOUNT		$ 200,000
Weighted average interest rate (percent)		1.21%
Interest Rate Swap, Expiring May 1, 2026 | Cash flow hedging | Designated as hedging instrument
Derivative [Line Items]
AMOUNT		$ 100,000
Weighted average interest rate (percent)		2.15%
Interest Rate Swap, Expiring Through 2027 | Subsequent event
Derivative [Line Items]
AMOUNT	$ 250,000

Derivative Financial Instrume_4

Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Other assets | Designated as hedging instrument | Interest rate swaps
Derivative [Line Items]
Liability derivatives	$ 16,136

Derivative Financial Instrume_5

Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Derivative [Line Items]
Loss recognized in AOCI on derivative	$ (6,083)	$ (36)	$ (12,905)	$ (2,079)
(Gain) loss reclassified from AOCI into income	(763)	(1,131)	(2,672)	(3,340)
Interest expense
Derivative [Line Items]
(Gain) loss reclassified from AOCI into income	763	1,131	2,672	3,340
Interest rate swaps
Derivative [Line Items]
Loss recognized in AOCI on derivative	(6,083)	(36)	(12,905)	(2,079)
Interest rate swaps | Interest expense
Derivative [Line Items]
(Gain) loss reclassified from AOCI into income	614	982	2,226	2,894
Settled treasury hedges
Derivative [Line Items]
Loss recognized in AOCI on derivative	0	0	0	0
Settled treasury hedges | Interest expense
Derivative [Line Items]
(Gain) loss reclassified from AOCI into income	107	107	320	320
Settled interest rate swaps
Derivative [Line Items]
Loss recognized in AOCI on derivative	0	0	0	0
Settled interest rate swaps | Interest expense
Derivative [Line Items]
(Gain) loss reclassified from AOCI into income	$ 42	$ 42	$ 126	$ 126

Derivative Financial Instrume_6

Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges (Details) $ in Millions	Sep. 30, 2022 USD ($)
Derivative [Line Items]
Derivatives in net asset position	$ 16.5
Active Interest Rate Swap
Derivative [Line Items]
Interest rate cash flow hedge gain (loss) to be reclassified to interest expense during the next 12 months	4.8
Settled Interest Rate Swaps
Derivative [Line Items]
Interest rate cash flow hedge gain (loss) to be reclassified to interest expense during the next 12 months	$ 0.6

Commitments and Contingencies -

Commitments and Contingencies - Construction Activity (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2021 USD ($)	Dec. 31, 2024 ft²	Jun. 30, 2024 ft²	Sep. 30, 2023 ft²	Sep. 30, 2022 USD ($) ft² property
Other Commitments [Line Items]
Project costs	$ 5,129				$ 4,001
Number of real estate properties | property					695
Medical office building | Dallas, TX
Other Commitments [Line Items]
Square footage of building under redevelopment | ft²					217,114
Project costs					$ 11,100
Medical office building | Tacoma, WA
Other Commitments [Line Items]
Project costs					$ 10,300
Approximate square feet | ft²					23,000
Medical office building | Nashville, TN
Other Commitments [Line Items]
Project costs					$ 15,300
Square footage of building to be demolished | ft²					81,000
Impairment charge	$ 5,000
Medical office building | Nashville, TN | Forecast
Other Commitments [Line Items]
Approximate square feet | ft²				106,194
Medical office building | Miami, FL
Other Commitments [Line Items]
Project costs					$ 10,600
Number of real estate properties | property					2
Medical office building | Miami, FL | Forecast
Other Commitments [Line Items]
Square footage of building under redevelopment | ft²			156,566
Medical office building | Raleigh, NC | Forecast
Other Commitments [Line Items]
Approximate square feet | ft²		120,694
Medical office building | Washinton, DC
Other Commitments [Line Items]
Square footage of building under redevelopment | ft²					259,290
Number of real estate properties | property					3
Medical office building 2 | Raleigh, NC
Other Commitments [Line Items]
Project costs					$ 15,300
Medical office building 2 | Washinton, DC
Other Commitments [Line Items]
Project costs					$ 2,000

Stockholders' Equity - Reconcil

Stockholders' Equity - Reconciliation of Beginning and Ending Common Stock Outstanding (Details) - shares	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Reconciliation of the beginning and ending common stock outstanding
Balance, beginning of period (in shares)	150,457,000
Balance, end of period (in shares)	380,572,000
Common Stock
Reconciliation of the beginning and ending common stock outstanding
Balance, beginning of period (in shares)	150,457,433	139,487,375
Issuance of common stock (in shares)	229,615,152	10,899,301
Nonvested share-based awards, net of withheld shares (in shares)	499,705	70,757
Balance, end of period (in shares)	380,572,290

Stockholders' Equity (Stock Tra

Stockholders' Equity (Stock Transactions - Narrative) (Details)			1 Months Ended	3 Months Ended				9 Months Ended
	Nov. 02, 2022 $ / shares	Jan. 03, 2022 USD ($) shares	Jan. 31, 2022 $ / shares	Sep. 30, 2022 USD ($) property $ / shares shares	Jun. 30, 2022 USD ($) property shares	Mar. 31, 2022 USD ($) shares	Sep. 30, 2021 $ / shares shares	Sep. 30, 2022 USD ($) property $ / shares shares	Sep. 30, 2021 $ / shares shares
Class of Stock [Line Items]
Dividends paid per common share, during the period (in dollars per share) | $ / shares				$ 0.31			$ 0.3025	$ 0.93	$ 0.9075
Award vesting period								3 years
Weighted average grant date fair value (in dollars per share) | $ / shares			$ 33.04
At the market equity offering program
Class of Stock [Line Items]
Percentage of restricted stock units			43%
Performance conditions
Class of Stock [Line Items]
Percentage of restricted stock units			57%
Weighted average grant date fair value (in dollars per share) | $ / shares			$ 31.68
Absolute TSR Component
Class of Stock [Line Items]
Weighted average grant date fair value (in dollars per share) | $ / shares			30.56
Relative TSR Component
Class of Stock [Line Items]
Weighted average grant date fair value (in dollars per share) | $ / shares			$ 41.30
Restricted stock
Class of Stock [Line Items]
Granted (in shares)				0				294,932
Award vesting period		5 years
Executive Incentive Program | Non-vested Stock Award
Class of Stock [Line Items]
Granted (in dollars per share) | $						$ 13,000,000
Granted (in shares)						415,184
Executive Incentive Program | Non-vested Stock Award | Minimum
Class of Stock [Line Items]
Award vesting period						3 years
Executive Incentive Program | Non-vested Stock Award | Maximum
Class of Stock [Line Items]
Award vesting period						8 years
Executive Incentive Program | Restricted stock
Class of Stock [Line Items]
Granted (in dollars per share) | $		$ 9,700,000
Granted (in shares)		294,932
Stock incentive plan
Class of Stock [Line Items]
Granted (in shares)				71,852			0	513,876	203,701
Stock incentive plan | Restricted stock
Class of Stock [Line Items]
Shares withheld to pay estimated withholding taxes (in shares)								8,745	51,972
Stock incentive plan | Restricted stock | Directors
Class of Stock [Line Items]
Granted (in dollars per share) | $				$ 1,800,000	$ 800,000
Granted (in shares)				1,036
Award vesting period					1 year
Number of directors | property				12	8			12
Shares issued during the period (in shares)				70,816	26,840
Stock incentive plan | Restricted stock | Minimum | Directors
Class of Stock [Line Items]
Award vesting period				1 year
Stock incentive plan | Restricted stock | Maximum | Directors
Class of Stock [Line Items]
Award vesting period				3 years
Share-based Payment Arrangement
Class of Stock [Line Items]
Weighted-average incremental shares of common stock excluded from the computation (in shares)									911,594
Options under the Employee Stock Option Plan
Class of Stock [Line Items]
Weighted-average incremental shares of common stock excluded from the computation (in shares)									63,383
Forward Contracts
Class of Stock [Line Items]
Weighted-average incremental shares of common stock excluded from the computation (in shares)									14,734
Subsequent event
Class of Stock [Line Items]
Dividends declared per common share, during the period (in dollars per share) | $ / shares	$ 0.31
Common Stock
Class of Stock [Line Items]
Amount remaining available for issuance under the new ATM | $				$ 750,000,000				$ 750,000,000

Stockholders' Equity - Computat

Stockholders' Equity - Computation of Basic and Diluted Earnings (Loss) Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Weighted average Common Shares outstanding
Weighted average common shares outstanding (in shares)	330,788,997	145,594,127	211,740,767	143,305,737
Non-vested shares (in shares)	(1,983,742)	(1,776,508)	(1,933,957)	(1,784,544)
Weighted average common shares outstanding - basic (in shares)	328,805,255	143,817,619	209,806,810	141,521,193
Dilutive effect of forward equity shares (in shares)	0	0	0	14,036
Dilutive effect of OP Units (in shares)	3,167,668	0	1,067,493	0
Dilutive effect of employee stock purchase plan (in shares)	58,461		69,687	78,200
Weighted average common shares outstanding - diluted (in shares)	332,031,384	143,817,619	210,943,990	141,613,429
Net income (loss)	$ 28,304	$ (2,066)	$ 76,661	$ 45,052
Dividends paid on nonvested share-based awards	(610)	(537)	(1,817)	(1,617)
Net income (loss) applicable to common stockholders- basic	27,694	(2,603)	74,844	43,435
Net income attributable to OP units	312	0	312	0
Net income (loss) applicable to common stockholders - diluted	$ 28,006	$ (2,603)	$ 75,156	$ 43,435
Basic earnings per common share - net income (in dollars per share)	$ 0.08	$ (0.02)	$ 0.36	$ 0.31
Diluted earnings per common share- net income (in dollars per share)	$ 0.08	$ (0.02)	$ 0.35	$ 0.31

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Activity under Stock-Based Incentive Plans and Restricted Stock Unit (Details) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Restricted stock
Summary of the activity under the incentive plans
Share-based awards, beginning of period (in shares)	294,932		0
Granted (in shares)	0		294,932
Vested (in shares)	0		0
Share-based awards, ending of period (in shares)	294,932		294,932
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Share-based awards, beginning of period, Weighted average grant date fair value		$ 0		$ 0
Granted, Weighted average grant date fair value (in dollar per share)		0		33.04
Vested, Weighted average grant date fair value (in dollar per share)		$ 0		$ 0
Stock incentive plan
Summary of the activity under the incentive plans
Share-based awards, beginning of period (in shares)	1,941,709	1,778,308	1,562,028	1,766,061
Granted (in shares)	71,852	0	513,876	203,701
Vested (in shares)	(7,434)	0	(68,481)	(191,454)
Forfeited (in shares)	(4,130)	(2,957)	(5,426)	(2,957)
Share-based awards, ending of period (in shares)	2,001,997	1,775,351	2,001,997	1,775,351

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Stock Options, Valuation Assumptions (Details)	1 Months Ended
	Jan. 31, 2022 $ / shares
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Volatility	30%
Expected term	3 years
Risk-free rate	1.02%
Stock price (in dollar per share)	$ 31.68

Stockholders' Equity - Summar_2

Stockholders' Equity - Summary of Activity under Employee Stock Purchase Plan (Details) - Employee stock purchase plan - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Summary of the Employee Stock Purchase Plan activity
Outstanding and exercisable, beginning of period (in shares)	405,534	389,414	348,514	341,647
Granted (in shares)	0	0	255,960	253,200
Exercised (in shares)	(4,576)	(5,323)	(17,094)	(24,300)
Forfeited (in shares)	(37,628)	(18,961)	(83,417)	(60,995)
Expired (in shares)	0	0	(140,633)	(144,422)
Outstanding and exercisable, end of period (in shares)	363,330	365,130	363,330	365,130

Fair Value of Financial Instr_3

Fair Value of Financial Instruments (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
CARRYING VALUE
Derivative [Line Items]
Notes and bonds payable	$ 5,570.1	$ 1,801.3
Real estate notes receivable	79	0
FAIR VALUE
Derivative [Line Items]
Notes and bonds payable	5,321	1,797.4
Real estate notes receivable	$ 79	$ 0